USRE40122E1 - Expandable stent-graft covered with expanded polytetrafluoroethylene - Google Patents

Expandable stent-graft covered with expanded polytetrafluoroethylene Download PDF

Info

Publication number
USRE40122E1
USRE40122E1 US11/067,620 US6762005A USRE40122E US RE40122 E1 USRE40122 E1 US RE40122E1 US 6762005 A US6762005 A US 6762005A US RE40122 E USRE40122 E US RE40122E
Authority
US
United States
Prior art keywords
stent
longitudinal
inter
average
expanded polytetrafluoroethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US11/067,620
Inventor
Paul J. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Starboard Value Intermediate Fund Lp As Collateral Agent
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/067,620 priority Critical patent/USRE40122E1/en
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCIMED LIFE SYSTEMS, INC.
Assigned to SCIMED LIFE SYSTEMS, INC. reassignment SCIMED LIFE SYSTEMS, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCHNEIDER (USA) INC.
Publication of USRE40122E1 publication Critical patent/USRE40122E1/en
Application granted granted Critical
Assigned to ACACIA RESEARCH GROUP LLC reassignment ACACIA RESEARCH GROUP LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Assigned to LIFEPORT SCIENCES LLC reassignment LIFEPORT SCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACACIA RESEARCH GROUP LLC
Anticipated expiration legal-status Critical
Assigned to STARBOARD VALUE INTERMEDIATE FUND LP, AS COLLATERAL AGENT reassignment STARBOARD VALUE INTERMEDIATE FUND LP, AS COLLATERAL AGENT PATENT SECURITY AGREEMENT Assignors: ACACIA RESEARCH GROUP LLC, AMERICAN VEHICULAR SCIENCES LLC, BONUTTI SKELETAL INNOVATIONS LLC, CELLULAR COMMUNICATIONS EQUIPMENT LLC, INNOVATIVE DISPLAY TECHNOLOGIES LLC, LIFEPORT SCIENCES LLC, LIMESTONE MEMORY SYSTEMS LLC, MERTON ACQUISITION HOLDCO LLC, MOBILE ENHANCEMENT SOLUTIONS LLC, MONARCH NETWORKING SOLUTIONS LLC, NEXUS DISPLAY TECHNOLOGIES LLC, PARTHENON UNIFIED MEMORY ARCHITECTURE LLC, R2 SOLUTIONS LLC, SAINT LAWRENCE COMMUNICATIONS LLC, STINGRAY IP SOLUTIONS LLC, SUPER INTERCONNECT TECHNOLOGIES LLC, TELECONFERENCE SYSTEMS LLC, UNIFICATION TECHNOLOGIES LLC
Assigned to MONARCH NETWORKING SOLUTIONS LLC, SUPER INTERCONNECT TECHNOLOGIES LLC, PARTHENON UNIFIED MEMORY ARCHITECTURE LLC, CELLULAR COMMUNICATIONS EQUIPMENT LLC, UNIFICATION TECHNOLOGIES LLC, LIMESTONE MEMORY SYSTEMS LLC, AMERICAN VEHICULAR SCIENCES LLC, LIFEPORT SCIENCES LLC, SAINT LAWRENCE COMMUNICATIONS LLC, BONUTTI SKELETAL INNOVATIONS LLC, NEXUS DISPLAY TECHNOLOGIES LLC, MOBILE ENHANCEMENT SOLUTIONS LLC, ACACIA RESEARCH GROUP LLC, INNOVATIVE DISPLAY TECHNOLOGIES LLC, STINGRAY IP SOLUTIONS LLC, R2 SOLUTIONS LLC, TELECONFERENCE SYSTEMS LLC reassignment MONARCH NETWORKING SOLUTIONS LLC RELEASE OF SECURITY INTEREST IN PATENTS Assignors: STARBOARD VALUE INTERMEDIATE FUND LP
Assigned to STARBOARD VALUE INTERMEDIATE FUND LP, AS COLLATERAL AGENT reassignment STARBOARD VALUE INTERMEDIATE FUND LP, AS COLLATERAL AGENT CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 052853 FRAME: 0153. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: LIFEPORT SCIENCES LLC
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C55/00Shaping by stretching, e.g. drawing through a die; Apparatus therefor
    • B29C55/22Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D23/00Producing tubular articles
    • B29D23/001Pipes; Pipe joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0057Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0078Quadric-shaped hyperboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0028Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in fibre orientations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2027/00Use of polyvinylhalogenides or derivatives thereof as moulding material
    • B29K2027/12Use of polyvinylhalogenides or derivatives thereof as moulding material containing fluorine
    • B29K2027/18PTFE, i.e. polytetrafluorethene, e.g. ePTFE, i.e. expanded polytetrafluorethene
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/005Oriented
    • B29K2995/0051Oriented mono-axially
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/005Oriented
    • B29K2995/0053Oriented bi-axially

Definitions

  • the present invention is generally directed to an expandable stent-graft made from a stent covered with expanded polytetrafluoroethylene.
  • covered expandable stent-grafts for bodily lumen repair is known in the art.
  • Covered expandable stent-grafts may be implanted in a radially compressed state, generally using a catheter, into blood vessels, urinary tracts, biliary tracts, esophageal, femoralpopliteac, venous, iliac, arterial-venus, venus cava, tracheo bronchial, abdominal aorta, thoracic aorta, coronary arteries, carotid arteries, colonic, fallopian, eustachian, ureter, urethra, prostrate or virtually any duct, gorge, or body chamber in a body.
  • the expandable stent-graft is generally positioned and released from a delivery catheter at a damaged area as desired. Expandable stent-grafts provide outward pressure and support for the body lumen walls, thus creating improved passageways. The addition of a covering on an expandable stent acts to reduce cell growth or occlusions in the interior of the lumen.
  • ePTFE expended polytetrafluoroethylene
  • the expandable stent-graft of the present invention is designed to provide an expanded polytetrafluoroethylene covering that expands and compresses in association with the stent structure as the stent structure expands and contracts.
  • the expandable stent-graft of the present invention may be used for repair and support of body vessel walls.
  • an expandable stent-graft includes a bonded layer of expanded polytetrafluoroethylene covering a stent so that the longitudinal fibrils of the cover are at least substantially extended to adapt to the stent longitudinal expansion when the stent is radially compressed; circumferential fibrils are at least substantially folded to adapt to the stent radial compression when the stent is longitudinally expanded; longitudinal fibrils are at least substantially folded to adapt to the stent longitudinal compression when the stent is radially expanded; and so the circumferential fibrils are at least substantially extended to adapt to the stent radial expansion when the stent is longitudinally compressed.
  • an expandable stent-graft includes a bonded layer of expanded polytetrafluoroethylene covering a stent so that the inter-nodule distance measured in the longitudinal direction between nodules is increased when the expandable stent-graft is radially compressed; the inter-nodule distance measured in the longitudinal direction between nodules is decreased when the expandable stent-graft is radially expanded; the inter-nodule distance measured in the circumferential direction between nodules is increased when the expandable stent-graft is longitudinally compressed; and so the inter-nodule distance measured in the circumferential direction between nodules is decreased when the expandable stent-graft is longitudinally expanded.
  • the present invention relates to an expandable prosthesis having (a) a discontinuous wall defining a lumen adapted to assume a longitudinally contracted position and a longitudinally expanded position; and (b) at least one layer of expended polytetrafluoroethylene having a first average longitudinal inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that it has a second average longitudinal inter-nodule distance when the wall is in the longitudinally contracted position, the second average longitudinal inter-nodule distance being less than the first average longitudinal inter-nodule distance.
  • the layer of expanded polytetrafluoroethylene may have (i) an average longitudinal inter-nodule distance of between about 0 and about 50 microns, preferably between about 5 and about 45 or between about 20 and about 30 microns, when the wall is in the longitudinally contracted position, and (ii) an average longitudinal inter-nodule distance of between about 50 and about 150 microns, preferably between about 60 and about 140 or between 80 and about 120 microns, when the wall is in the longitudinally expanded position.
  • the present invention also relates to an expandable prosthesis having (a) a discontinuous wall defining a lumen adapted to assume a radially contracted position and a radially expanded position; and (b) at least one tubular layer of an expanded polytetrafluoroethylene having a first average circumferential inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that it has a second average circumferential inter-nodule distance when the wall is in the radially contracted state, the second average circumferential inter-nodule distance being less than the first average circumferential inter-nodule distance.
  • the tubular layer of expanded polytetrafluoroethylene may have (i) an average circumferential inter-nodule distance of between about 0 and about 75 microns, preferably between about 5 and about 70 or between about 20 and about 50 microns, when the wall is in the radially contracted position, and (ii) an average circumferential inter-nodule distance of between about 75 and about 150 microns, preferably between about 80 and about 140 microns or between about 80 and about 120 microns, when the wall is in the radially expanded position.
  • the present invention also relates to an expandable prosthesis having (a) a discontinuous wall generally defining a lumen adapted to assume a longitudinally expanded position and a longitudinally contracted position; and (b) at least one layer of expanded polytetrafluoroethylene having a first average longitudinal inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that the polytetrafluoroethylene has a second average longitudinal inter-nodule distance between 0 and 99 percent of the first average longitudinal inter-nodule distance when the wall is in the longitudinally contracted position.
  • the second average longitudinal inter-nodule distance may be between about 20 and about 50 percent of the first average longitudinal inter-nodule distance when the wall is in the longitudinally contracted position.
  • the present invention also relates to an expandable prosthesis having (a) a discontinuous wall generally defining a lumen adapted to assume a radially expanded position and a radially contracted position; and (b) at least one layer of expanded polytetrafluoroethylene having a first average circumferential inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that the polytetrafluoroethylene has a second average circumferential inter-nodule distance less than about 50 percent of the first average circumferential inter-nodule distance when the wall is in the radially contracted position.
  • the second average circumferential inter-nodule distance may be less than about 25 percent of the first average circumferential inter-nodule distance when the wall is in the radially contracted position.
  • the present invention also relates to an expandable prosthesis having (a) a discontinuous wall defining a lumen adapted to assume a radially expended position and a radially contracted position; and (b) at least one layer of expanded polytetrafluoroethylene having a first average longitudinal inter-nodule distance and a first average circumferential inter-nodule distance in a free state, the layer of the polytetrafluoroethylene affixed to the wall such that the polytetrafluoroethylene has a second average longitudinal inter-nodule distance between 0 and 99 percent of the first average longitudinal inter-nodule distance when the wall is in the radially expanded position and a second average circumferential inter-nodule distance less than about 50 percent of the first average circumferential inter-nodule distance when the wall is in the radially contracted position.
  • the second average longitudinal inter-nodule distance may be between about 20 and about 50 percent of the first average longitudinal inter-nodule distance, and the second average circumferential inter-nodule distance may be less than about 25 percent of the first average circumferential inter-nodule distance.
  • the present invention also relates to an expandable stent-graft having (a) a braided self-expanding stent characterized by a longitudinal shortening upon radial expansion from a first longitudinal stent length to a second longitudinal stent length; and (b) at least one tubular layer of biaxially oriented expanded polytetrafluoroethylene comprising nodules and fibrils affixed to the stent characterized by a shortening of average longitudinal inter-nodule distance upon radial expansion from a first average longitudinal inter-nodule distance to a second average longitudinal inter-nodule distance; wherein the ratio of first longitudinal stent length to second longitudinal stent length is within about 25 percent of, and is preferably substantially the same as, the ratio of first average longitudinal inter-nodule distance to a second average inter-nodule distance.
  • the present invention also relates an expandable stent-graft having (a) a braided self-expanding stent characterized by a longitudinal shortening upon radial expansion; (b) at least one layer of uniaxially oriented expanded polytetrafluoroethylene affixed to the stent, the polytetrafluoroethylene characterized by having substantially no nodules.
  • the present invention also relates to a method of making an expandable prosthesis including (a) providing a self-expanding braided stent having a longitudinal orientation in an at least partially radially expended state; (b) providing at least one layer of expanded polytetrafluoroethylene having a longitudinal orientation and a first average longitudinal inter-nodule distance in a free state; (c) longitudinally compressing the layer of expanded polytetrafluoroethylene so that the resulting longitudinally compressed layer has a second average longitudinal inter-nodule distance which is less than the first average longitudinal inter-nodule distance; and (d) affixing the longitudinally compressed layer of expanded polytetrafluoroethylene to the self-expanding braided stent in the at least partially radially expanded state such that the longitudinal orientations of the stent and layer of expanded polytetrafluoroethylene substantially correspond with one another.
  • FIG. 1 depicts a micrograph view showing the nodules and fibrils of a biaxially oriented, expanded polytetrafluoroethylene material at a 2000 ⁇ magnification.
  • FIG. 2 depicts an illustration of the nodule and fibril relationship and the inter-nodule distances of a biaxially oriented, expanded polytetrafluoroethylene material on a stent that is longitudinally compressed.
  • FIG. 3 depicts a view of the nodule and fibril relationship and the inter-nodule distances of a biaxially oriented, expanded polytetrafluoroethylene material on a stent that is radially compressed.
  • FIGS. 4-12 illustrates steps of making the expandable stent-graft according to the present invention, wherein:
  • FIG. 4 depicts a mandrel
  • FIG. 5 depicts the biaxially oriented expanded polytetrafluoroethylene (ePTFE) material (tube, sheet or strips or any combination of tube, sheet or strips) at least partially covering the mandrel;
  • ePTFE expanded polytetrafluoroethylene
  • FIG. 6 depicts the ePTFE material being longitudinally compressed onto the mandrel and further illustrates the longitudinal fibrils being substantially folded and the circumferential fibrils allowed to remain substantially extended;
  • FIG. 7 depicts an expanded stent, having an inside diameter greater than the combined outside diameter of the mandrel and the ePTFE material, being positioned over the longitudinally compressed ePTFE material on the mandrel;
  • FIG. 8 depicts a section view of the stent over the longitudinally compressed ePTFE material
  • FIG. 9 depicts an end view of the stent over the longitudinally compressed ePTFE material
  • FIG. 10 depicts an outer layer of longitudinally compressed ePTFE material positioned over the stent, an inner layer of longitudinally compressed ePTFE material and the mandrel;
  • FIG. 11 depicts a section view of an outer layer of longitudinally compressed ePTFE material positioned over the stent and an inner layer of longitudinally compressed ePTFE material.
  • the ePTFE materials are bonded over or throughout the outside surface, inside surface or throughout the discontinuous wall of the stent;
  • FIG. 12 depicts an end view of an outer layer of longitudinally compressed ePTFE material positioned over the stent and an inner layer of longitudinally compressed ePTFE material.
  • the ePTFE materials are bonded over or throughout the outside surface, inside surface or throughout the discontinuous wall of the stent.
  • FIG. 13 depicts an illustration of the various states of the ePTFE on the stent such as when the expandable stent-graft is radially compressed or radially expanded.
  • the present invention relates to a flexible and generally cylindrical expandable stent-graft 20 that may be made from a stent 12 and a covering of biaxially oriented, expanded polytetrafluoroethylene material 3 .
  • the biaxially oriented, expanded polytetrafluoroethylene material 3 has a microstructure comprised of nodules 2 and fibrils 4 , 4 ′ and inter-nodule distances ⁇ , ⁇ ′, ⁇ , ⁇ ′.
  • biaxial, expanded polytetrafluoroethylene material as used herein means a biaxially oriented expanded polytetrafluoroethylene material.
  • uniaxial, expanded polytetrafluoroethylene material as used herein means a uniaxially oriented expanded polytetrafluoroethylene material.
  • the average longitudinal inter-nodule distance of either uniaxial or biaxial expanded polytetrafluoroethylene may be between about 5 and about 150 microns in the free state, preferably between about 20 and about 60 microns in the free state.
  • the longitudinal orientation and resulting longitudinal inter-nodule distances are based on the orientation when the expanded polytetrafluoroethylene is placed on a stent, such that the longitudinal orientation of the stent and expanded polytetrafluoroethylene substantially correspond with one another.
  • the expanded polytetrafluoroethylene is in a free state when no force is applied thereto.
  • a preferred embodiment of the expandable stent-graft 20 of the present invention may be designed so that its expanded polytetrafluoroethylene covering 10 ′ is associated with the expansion or compression of the stent 12 (FIG. 13 ), as the expandable stent-graft 20 is inserted in a delivery catheter or deployed into a body lumen.
  • the expandable stent-graft 20 is intended for repair and support of body vessel walls.
  • a preferred embodiment of the expandable stent-graft 20 of the present invention may be made from a braided stent 12 such as the one described in U.S. Pat. No. 5,061,275 to Wallsten.
  • a self-expanding stent is characterized in that the stent longitudinally contracts as it radially expands, and longitudinally expands as it radially contracts.
  • Other, non-braided stents are known in the art which share this characteristic.
  • This stent 12 may be at least partially covered, individually or in combination, with at least one layer of tube, sheet, strips or film of biaxial expanded polytetrafluoroethylene material 10 on the inside surface 14 , outside surface 18 , inside surface 14 and outside surface 18 , or between the inside surface 14 and the outside surface 18 of the discontinuous wall of a stent 12 (FIGS. 7 - 13 ).
  • the stent 12 and expanded polytetrafluoroethylene covering 10 ′ may be bonded together, for instance under heat and pressure, to form the expandable stent-graft 20 .
  • Another method of bonding may include the use of another polymer such as a polyurethane or FEP which has a lower melt point.
  • the expandable stent-graft 20 of the present invention offers the properties of a stent 12 and the benefits of an expanded polytetrafluoroethylene covering that conforms to the compliance and distortion of the underlying stent 12 .
  • the expanded polytetrafluoroethylene microstructure ( FIGS. 1-3 ) and it's orientation on the stent 12 ( FIGS. 5-13 ) relate to the present invention.
  • the expandable stent-graft 20 has characteristics that may reduce the occlusion of the lumen and improve healing of the damaged body vessels.
  • expandable stent-graft 20 of the present invention may comprise a uniaxial, expanded polytetrafluoroethylene covering on at least part of the inside surface 14 , outside surface 18 , inside surface 14 and outside surface 18 or between the inside surface 14 and the outside surface 18 of the stent 12 .
  • the uniaxial, expanded polytetrafluoroethylene covering may be comprised substantially of fibrils as the nodules have been reduced substantially to zero.
  • Other uniaxial, expanded polytetrafluoroethylene coverings may have discrete nodules so that the nodules are substantially unconnected to one another.
  • expandable stent-graft 20 of the present invention may comprise a uniaxial, expanded polytetrafluoroethylene covering and a biaxial, expanded polytetrafluoroethylene covering 10 ′ on at least part of the inside surface 14 , outside surface 18 , inside surface 14 and outside surface 18 , or between the inside surface 14 and the outside surface 18 of the stent 12 .
  • the uniaxial, expanded polytetrafluoroethylene covering is comprised substantially of fibrils and is longitudinally oriented on the stent.
  • the expanded polytetrafluoroethylene covering may correspondingly expand and contract with the stent 12 .
  • the nodule and fibril relationship may change within the biaxial expanded polytetrafluoroethylene material 10 ′ and the fibril relationship within the uniaxial expanded polytetrafluoroethylene material and allows the covering to conform to the shape to of the stent 12 .
  • FIG. 13 illustrates an expandable stent-graft of the present invention with the end portions in at least partially radially expanded states and the mid-section in an at least partially radially contracted state.
  • the preferred nodule and fibril relationship of the biaxial, expanded polytetrafluoroethylene or the preferred fibril relationship of the uniaxial expanded polytetrafluoroethylene material is dependent on the dimensions of the stent 12 being covered.
  • the preferred nodule and fibril relationship of the biaxial, expanded polytetrafluoroethylene in the free state or the preferred fibril relationship of the uniaxial, expanded polytetrafluoroethylene in the free state may have a circumferential fibril length ranging from about 5 microns to about 150 microns; an inter-nodule distance measured in the circumferential direction ranging from about 5 microns to about 150 microns; a longitudinal fibril length ranging from about 5 microns to about 100 microns; or an inter-nodule distance measured in the longitudinal direction ranging from about 5 microns to about 100 microns to be sufficient to offer the desired range of performance for the present invention.
  • the nodules 2 and fibrils 4 , 4 ′ within the biaxial, expanded polytetrafluoroethylene material may be oriented onto the stent 12 so that the longitudinal fibrils are at least substantially extended 4 ′ to adapt to the stent 12 longitudinal expansion when the stent 12 is radially compressed; the circumferential fibrils are at least substantially folded 6 ′ to adapt to the stent radial compression when the stent 12 is longitudinally expanded; the longitudinal fibrils are at least substantially folded 4 to adapt to the stent 12 longitudinal compression when the stent 12 is radially expanded; or the circumferential fibrils are at least substantially extended 6 to adapt to the stent radial expansion when the stent 12 is longitudinally compressed ( FIGS.
  • the present invention also relates to a method of bonding an expanded polytetrafluoroethylene material 10 , 10 ′ onto a stent 12 so that the inter-nodule distance measured in the longitudinal direction between nodules is increased when the expandable stent-graft 20 is radially compressed; the inter-nodule distance measured in the longitudinal direction between nodules is decreased when the expandable stent-graft 20 is radially expanded; the inter-nodule distance measured in the circumferential direction between nodules 2 is increased when the expandable stent-graft 20 is longitudinally compressed; or the inter-nodule distance measured in the circumferential direction between nodules 2 is decreased when the expandable stent-graft is longitudinally expanded.
  • the stent 12 and expanded polytetrafluoroethylene covering 10 ′ substantially are bonded together and substantially coextensively compress, expand or conform in shape, when radial and longitudinal forces expand or compress the expandable stent-graft 20 .
  • the expandable stent-graft 20 may compress when inserted into a delivery catheter or the expandable stent-graft 20 may expand when deployed from the catheter into a body vessel.
  • the biaxial, expanded polytetrafluoroethylene 10 , 10 ′ or uniaxial, expanded polytetrafluoroethylene covering are not elastomers, yet, they each expand and contract with the radial or longitudinal expansion and compression forces on the expandable stent-graft 20 .
  • the biaxial expanded polytetrafluoroethylene or uniaxial expanded polytetrafluoroethylene coverings may expand and compress on the expandable stent-graft 20 and have reduced folds, flaps, pillowing or kinks, thus, reducing the thrombogenic effect that may result from uneven or rough to vessel surfaces.
  • the orientation of the ePTFE and the interaction of the nodules 2 and fibrils 4 , 4 ′, 6 , 6 ′ may allow the inside surface 14 and/or the outside surface 18 to be substantially smooth in both contracted and expanded states.
  • expandable stent-graft 20 of the present invention offers a substantially smooth covering during the radial and longitudinal compression and expansion of the expandable stent-graft 20 .
  • Radial compression and longitudinal expansion of the expandable stent-graft 20 occurs when the expandable stent-graft 20 is inserted into a catheter.
  • Radial expansion and longitudinal compression of the expandable stent-graft 20 occurs when the expandable stent-graft 20 is deployed into various sized body vessels.
  • the expandable stent-graft 20 of the present invention may provide a surface that promotes increased fluid flow, reduced fluid turbulence, and overall improved compliance properties when compared to conventional covered stents. Many of the present invention characteristics are desired by medical practitioners, when repairing and healing body vessels.
  • the expanded polytetrafluoroethylene covering on the stent 12 requires little additional force to expand or contract.
  • the biaxial, expanded polytetrafluoroethylene material 10 ′ or uniaxial expanded polytetrafluoroethylene material substantially adapts to the radial and longitudinal expansion and compression of the stent 12 .
  • the expanded polytetrafluoroethylene covering is intended to enhance the benefits of a conventional stent 12 by adding graft capabilities, without, reducing the compliance or performance of the expandable stent-graft 20 .
  • the expandable stent-graft 20 is generally made in the shape of a cylindrical lumen having a discontinuous wall covered with expanded polytetrafluoroethylene.
  • a preferred embodiment of the expandable stent-graft of the present invention has a nodule and fibril relationship in the biaxial, expanded polytetrafluoroethylene covering 10 ′ or a fibril relationship in the uniaxial, expanded polytetrafluoroethylene covering, respectively, such that the expandable stent-graft 20 expands longitudinally up to about 300% when radially compressed as compared to it's length when in a radially expanded state.
  • expandable stent-graft 20 of the present invention has a nodule and fibril relationship in the biaxial, expanded polytetrafluoroethylene covering 10 ′ or a fibril relationship in the uniaxial, expanded polytetrafluoroethylene covering such that the expandable stent-graft 20 expands radially up to about 1000% of its fully radially compressed diameter measurement.
  • expandable stent-graft 20 of the present invention may comprise at least one partial layer of biaxial, expanded polytetrafluoroethylene or a uniaxial 10 ′, expanded polytetrafluoroethylene or a combination of a biaxial, expanded polytetrafluoroethylene 10 ′ and a uniaxial, expanded polytetrafluoroethylene material.
  • the uniaxial, expanded polytetrafluoroethylene material has a fibril relationship and is comprised substantially of fibrils as the nodules 2 have been reduced essentially to nearly zero.
  • Each layer of biaxial or uniaxial, expanded polytetrafluoroethylene material may have a thickness ranging from about 10 to about 500 microns and may be made from tube, sheet, film or a plurality of strips disposed on the inner surface 14 of the discontinuous wall, outer surface 18 of the discontinuous wall, both the inner surface 14 and outer surface 18 of the discontinuous wall of the stent or between the inner surface 14 and outer surface 18 of the discontinuous wall of the stent 12 including the voids between the mesh of the walls.
  • the discontinuous wall and the expanded polytetrafluoroethylene material are bonded at a temperature range of about 340° C. to about 390° C.
  • the discontinuous wall of the stent 12 may be coated with expanded polytetrafluoroethylene, polytetrafluoroethylene or both expanded polytetrafluoroethylene and polytetrafluoroethylene on at least part of its surface.
  • the preferred embodiments of the expandable stent-graft 20 of the present invention may be produced by the method of placing a biaxial expanded polytetrafluoroethylene material 10 on a mandrel 8 in an at least partially expanded state, and then longitudinally compressing the biaxial, expanded polytetrafluoroethylene material 10 which it is positioned on the mandrel 8 so that the longitudinal fibrils are at least substantially folded 4 and the circumferential fibrils are at least substantially extended 6 or so that the inter-nodule distance measured in the longitudinal direction between nodules 2 is decreased and the inter-nodule distance measured in the circumferential direction between nodules 2 is increased.
  • a stent 12 having an inside diameter greater than the combined diameter of the expanded polytetrafluoroethylene material and the mandrel 8 is then placed onto the outer surface of the expanded polytetrafluoroethylene material. Contact is then maintained between the stent and the expanded polytetrafluoroethylene material while the covering and the stent are heated to a temperature ranging from about 340° C. to about 390° C. for a time ranging from about 1 minute to about 15 minutes to bond the expanded polytetrafluoroethylene material to the discontinuous wall of the stent. The expandable stent-graft is then cooled and removed from the mandrel.
  • the preferred embodiments of the expandable stent-graft of the present invention may also be produced by the method of placing a biaxial expanded polytetrafluoroethylene material on a mandrel and then longitudinally expanding or stretching the biaxial, expanded polytetrafluoroethylene material while it is positioned on the mandrel so that the longitudinal fibrils are at least substantially extended and the circumferential fibrils are at least substantially folded. Also, the inter-nodule distance measured in the longitudinal direction between nodules 2 may be increased and the inter-nodule distance measured in the circumferential direction between nodules 2 may be decreased.
  • a stent having a diameter greater than the combined diameter of the expanded polytetrafluoroethylene material and the mandrel is then placed onto the outer surface of the expanded polytetrafluoroethylene material.
  • the expandable stent-graft is radially compressed and contact is then maintained between the stent and the expanded polytetrafluoroethylene material while the covering and the stent are heated to a temperature ranging from about 340° C. to about 390° C. for a time ranging from about 1 minute to about 15 minutes to bond the expanded polytetrafluoroethylene material to the discontinuous wall of the stent.
  • the expandable stent-graft is then cooled and removed from the mandrel.
  • the preferred embodiment of the expandable stent-graft of the present invention may also be produced by longitudinally compressing the expanded polytetrafluoroethylene material, prior to the step of placing the expanded polytetrafluoroethylene material on the mandrel.
  • the preferred embodiment of the expandable stent-graft of the present invention may also be produced by longitudinally expanding or stretching the expanded polytetrafluoroethylene material prior to the step of placing the expanded polytetrafluoroethylene material on the mandrel.
  • An expanded polytetrafluoroethylene tape can be diagonally wound under tension about an at least partially expanded stent. Additional compressible and expandable objects of varying size, shape, compliance or dimension may also be able to take advantage of the expanded polytetrafluoroethylene coverings.

Abstract

The expandable stent-graft generally defines a cylindrical lumen made from a stent having a discontinuous wall that is at least substantially covered with an expended polytetrafluoroethylene material. The expanded polytetrafluoroethylene covering may be a biaxially oriented, expanded polytetrafluoroethylene material having nodules and longitudinal and circumferential fibrils or a uniaxially oriented, expanded polytetrafluoroethylene material. The expandable stent-graft expands and compresses in association with the stent structure as it is contracted and expanded.

Description

The present application claims priority to and is a divisional application of application U.S. Ser. No. 08/988,725, now U.S. Pat. No. 6,165,211, filed Dec. 11, 1997, which is a divisional application of 08/751,884 now U.S. Pat. No. 5,788,626 filed Nov. 18, 1996, which claims priority to provisional application No. 60/007,435, filed Nov. 21, 1995.
BACKGROUND OF THE INVENTION
The present invention is generally directed to an expandable stent-graft made from a stent covered with expanded polytetrafluoroethylene.
The use of covered expandable stent-grafts for bodily lumen repair is known in the art. Covered expandable stent-grafts may be implanted in a radially compressed state, generally using a catheter, into blood vessels, urinary tracts, biliary tracts, esophageal, femoralpopliteac, venous, iliac, arterial-venus, venus cava, tracheo bronchial, abdominal aorta, thoracic aorta, coronary arteries, carotid arteries, colonic, fallopian, eustachian, ureter, urethra, prostrate or virtually any duct, gorge, or body chamber in a body.
The expandable stent-graft is generally positioned and released from a delivery catheter at a damaged area as desired. Expandable stent-grafts provide outward pressure and support for the body lumen walls, thus creating improved passageways. The addition of a covering on an expandable stent acts to reduce cell growth or occlusions in the interior of the lumen.
Coverings and covered expandable stents that are known in the art are disclosed in the following documents: U.S. Pat. No. 3,953,566 to Gore; U.S. Pat. No. 4,655,771 to Wallsten; U.S. Pat. No. 5,061,275 to Wallsten et al; U.S. Pat. No. 5,112,900 to Buddenhagen et al; U.S. Pat. No. 5,123,917 to Lee; U.S. Pat. No. 5,282,823 to Schwartz et al; U.S. Pat. No. 5,282,824 to Gianturco, U.S. Pat. No. 4,850,999 to Planck, European Patent Application No. 0 621 015 A1 to Lukic, European Patent Application No. 0 551 179 A1 to Palmaz, DE 3918736-A1 to Vallbracht, Patent Cooperation Treaty Application WO 95/05131 to Gore, Patent Cooperation Treaty Application WO 95/05132 to Gore, Patent Cooperation Treaty Application WO 95/05555 to Gore; Patent Cooperation Treaty Application WO 87/04935 to Fischell. (All documents cited herein, including the forgoing, are incorporated herein in their entireties for all purposes.)
It is an object of the present invention to provide an expandable stent-graft which is covered, at least in part, with expended polytetrafluoroethylene (ePTFE).
Other objects of the invention will become apparent to those skilled in the art through familiarization with the specification and claims herein.
SUMMARY OF THE INVENTION
The expandable stent-graft of the present invention is designed to provide an expanded polytetrafluoroethylene covering that expands and compresses in association with the stent structure as the stent structure expands and contracts. The expandable stent-graft of the present invention may be used for repair and support of body vessel walls.
In preferred embodiments of the present invention, an expandable stent-graft includes a bonded layer of expanded polytetrafluoroethylene covering a stent so that the longitudinal fibrils of the cover are at least substantially extended to adapt to the stent longitudinal expansion when the stent is radially compressed; circumferential fibrils are at least substantially folded to adapt to the stent radial compression when the stent is longitudinally expanded; longitudinal fibrils are at least substantially folded to adapt to the stent longitudinal compression when the stent is radially expanded; and so the circumferential fibrils are at least substantially extended to adapt to the stent radial expansion when the stent is longitudinally compressed.
In other preferred embodiments of the present invention, an expandable stent-graft includes a bonded layer of expanded polytetrafluoroethylene covering a stent so that the inter-nodule distance measured in the longitudinal direction between nodules is increased when the expandable stent-graft is radially compressed; the inter-nodule distance measured in the longitudinal direction between nodules is decreased when the expandable stent-graft is radially expanded; the inter-nodule distance measured in the circumferential direction between nodules is increased when the expandable stent-graft is longitudinally compressed; and so the inter-nodule distance measured in the circumferential direction between nodules is decreased when the expandable stent-graft is longitudinally expanded.
In sum, the present invention relates to an expandable prosthesis having (a) a discontinuous wall defining a lumen adapted to assume a longitudinally contracted position and a longitudinally expanded position; and (b) at least one layer of expended polytetrafluoroethylene having a first average longitudinal inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that it has a second average longitudinal inter-nodule distance when the wall is in the longitudinally contracted position, the second average longitudinal inter-nodule distance being less than the first average longitudinal inter-nodule distance. The layer of expanded polytetrafluoroethylene may have (i) an average longitudinal inter-nodule distance of between about 0 and about 50 microns, preferably between about 5 and about 45 or between about 20 and about 30 microns, when the wall is in the longitudinally contracted position, and (ii) an average longitudinal inter-nodule distance of between about 50 and about 150 microns, preferably between about 60 and about 140 or between 80 and about 120 microns, when the wall is in the longitudinally expanded position.
The present invention also relates to an expandable prosthesis having (a) a discontinuous wall defining a lumen adapted to assume a radially contracted position and a radially expanded position; and (b) at least one tubular layer of an expanded polytetrafluoroethylene having a first average circumferential inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that it has a second average circumferential inter-nodule distance when the wall is in the radially contracted state, the second average circumferential inter-nodule distance being less than the first average circumferential inter-nodule distance. The tubular layer of expanded polytetrafluoroethylene may have (i) an average circumferential inter-nodule distance of between about 0 and about 75 microns, preferably between about 5 and about 70 or between about 20 and about 50 microns, when the wall is in the radially contracted position, and (ii) an average circumferential inter-nodule distance of between about 75 and about 150 microns, preferably between about 80 and about 140 microns or between about 80 and about 120 microns, when the wall is in the radially expanded position.
The present invention also relates to an expandable prosthesis having (a) a discontinuous wall generally defining a lumen adapted to assume a longitudinally expanded position and a longitudinally contracted position; and (b) at least one layer of expanded polytetrafluoroethylene having a first average longitudinal inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that the polytetrafluoroethylene has a second average longitudinal inter-nodule distance between 0 and 99 percent of the first average longitudinal inter-nodule distance when the wall is in the longitudinally contracted position. The second average longitudinal inter-nodule distance may be between about 20 and about 50 percent of the first average longitudinal inter-nodule distance when the wall is in the longitudinally contracted position.
The present invention also relates to an expandable prosthesis having (a) a discontinuous wall generally defining a lumen adapted to assume a radially expanded position and a radially contracted position; and (b) at least one layer of expanded polytetrafluoroethylene having a first average circumferential inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the wall such that the polytetrafluoroethylene has a second average circumferential inter-nodule distance less than about 50 percent of the first average circumferential inter-nodule distance when the wall is in the radially contracted position. The second average circumferential inter-nodule distance may be less than about 25 percent of the first average circumferential inter-nodule distance when the wall is in the radially contracted position.
The present invention also relates to an expandable prosthesis having (a) a discontinuous wall defining a lumen adapted to assume a radially expended position and a radially contracted position; and (b) at least one layer of expanded polytetrafluoroethylene having a first average longitudinal inter-nodule distance and a first average circumferential inter-nodule distance in a free state, the layer of the polytetrafluoroethylene affixed to the wall such that the polytetrafluoroethylene has a second average longitudinal inter-nodule distance between 0 and 99 percent of the first average longitudinal inter-nodule distance when the wall is in the radially expanded position and a second average circumferential inter-nodule distance less than about 50 percent of the first average circumferential inter-nodule distance when the wall is in the radially contracted position. The second average longitudinal inter-nodule distance may be between about 20 and about 50 percent of the first average longitudinal inter-nodule distance, and the second average circumferential inter-nodule distance may be less than about 25 percent of the first average circumferential inter-nodule distance.
The present invention also relates to an expandable stent-graft having (a) a braided self-expanding stent characterized by a longitudinal shortening upon radial expansion from a first longitudinal stent length to a second longitudinal stent length; and (b) at least one tubular layer of biaxially oriented expanded polytetrafluoroethylene comprising nodules and fibrils affixed to the stent characterized by a shortening of average longitudinal inter-nodule distance upon radial expansion from a first average longitudinal inter-nodule distance to a second average longitudinal inter-nodule distance; wherein the ratio of first longitudinal stent length to second longitudinal stent length is within about 25 percent of, and is preferably substantially the same as, the ratio of first average longitudinal inter-nodule distance to a second average inter-nodule distance. The present invention also relates an expandable stent-graft having (a) a braided self-expanding stent characterized by a longitudinal shortening upon radial expansion; (b) at least one layer of uniaxially oriented expanded polytetrafluoroethylene affixed to the stent, the polytetrafluoroethylene characterized by having substantially no nodules.
The present invention also relates to a method of making an expandable prosthesis including (a) providing a self-expanding braided stent having a longitudinal orientation in an at least partially radially expended state; (b) providing at least one layer of expanded polytetrafluoroethylene having a longitudinal orientation and a first average longitudinal inter-nodule distance in a free state; (c) longitudinally compressing the layer of expanded polytetrafluoroethylene so that the resulting longitudinally compressed layer has a second average longitudinal inter-nodule distance which is less than the first average longitudinal inter-nodule distance; and (d) affixing the longitudinally compressed layer of expanded polytetrafluoroethylene to the self-expanding braided stent in the at least partially radially expanded state such that the longitudinal orientations of the stent and layer of expanded polytetrafluoroethylene substantially correspond with one another.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing features, objects and advantages of the present invention will become apparent to those skilled in the art from the following detailed description of preferred embodiments, especially when considered in conjunction with the accompanying drawings in which:
FIG. 1 depicts a micrograph view showing the nodules and fibrils of a biaxially oriented, expanded polytetrafluoroethylene material at a 2000× magnification.
FIG. 2 depicts an illustration of the nodule and fibril relationship and the inter-nodule distances of a biaxially oriented, expanded polytetrafluoroethylene material on a stent that is longitudinally compressed.
FIG. 3 depicts a view of the nodule and fibril relationship and the inter-nodule distances of a biaxially oriented, expanded polytetrafluoroethylene material on a stent that is radially compressed.
FIGS. 4-12 illustrates steps of making the expandable stent-graft according to the present invention, wherein:
FIG. 4 depicts a mandrel;
FIG. 5 depicts the biaxially oriented expanded polytetrafluoroethylene (ePTFE) material (tube, sheet or strips or any combination of tube, sheet or strips) at least partially covering the mandrel;
FIG. 6 depicts the ePTFE material being longitudinally compressed onto the mandrel and further illustrates the longitudinal fibrils being substantially folded and the circumferential fibrils allowed to remain substantially extended;
FIG. 7 depicts an expanded stent, having an inside diameter greater than the combined outside diameter of the mandrel and the ePTFE material, being positioned over the longitudinally compressed ePTFE material on the mandrel;
FIG. 8 depicts a section view of the stent over the longitudinally compressed ePTFE material;
FIG. 9 depicts an end view of the stent over the longitudinally compressed ePTFE material;
FIG. 10 depicts an outer layer of longitudinally compressed ePTFE material positioned over the stent, an inner layer of longitudinally compressed ePTFE material and the mandrel;
FIG. 11 depicts a section view of an outer layer of longitudinally compressed ePTFE material positioned over the stent and an inner layer of longitudinally compressed ePTFE material. The ePTFE materials are bonded over or throughout the outside surface, inside surface or throughout the discontinuous wall of the stent; and
FIG. 12 depicts an end view of an outer layer of longitudinally compressed ePTFE material positioned over the stent and an inner layer of longitudinally compressed ePTFE material. The ePTFE materials are bonded over or throughout the outside surface, inside surface or throughout the discontinuous wall of the stent.
FIG. 13 depicts an illustration of the various states of the ePTFE on the stent such as when the expandable stent-graft is radially compressed or radially expanded.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring now to FIGS. 1-3, the present invention relates to a flexible and generally cylindrical expandable stent-graft 20 that may be made from a stent 12 and a covering of biaxially oriented, expanded polytetrafluoroethylene material 3. The biaxially oriented, expanded polytetrafluoroethylene material 3 has a microstructure comprised of nodules 2 and fibrils 4, 4′ and inter-nodule distances α, α′, θ, θ′.
The term biaxial, expanded polytetrafluoroethylene material as used herein means a biaxially oriented expanded polytetrafluoroethylene material. The term uniaxial, expanded polytetrafluoroethylene material as used herein means a uniaxially oriented expanded polytetrafluoroethylene material. The average longitudinal inter-nodule distance of either uniaxial or biaxial expanded polytetrafluoroethylene may be between about 5 and about 150 microns in the free state, preferably between about 20 and about 60 microns in the free state. The longitudinal orientation and resulting longitudinal inter-nodule distances are based on the orientation when the expanded polytetrafluoroethylene is placed on a stent, such that the longitudinal orientation of the stent and expanded polytetrafluoroethylene substantially correspond with one another. The expanded polytetrafluoroethylene is in a free state when no force is applied thereto.
A preferred embodiment of the expandable stent-graft 20 of the present invention may be designed so that its expanded polytetrafluoroethylene covering 10′ is associated with the expansion or compression of the stent 12 (FIG. 13), as the expandable stent-graft 20 is inserted in a delivery catheter or deployed into a body lumen. The expandable stent-graft 20 is intended for repair and support of body vessel walls.
A preferred embodiment of the expandable stent-graft 20 of the present invention may be made from a braided stent 12 such as the one described in U.S. Pat. No. 5,061,275 to Wallsten. Such a self-expanding stent is characterized in that the stent longitudinally contracts as it radially expands, and longitudinally expands as it radially contracts. Other, non-braided stents are known in the art which share this characteristic. This stent 12 may be at least partially covered, individually or in combination, with at least one layer of tube, sheet, strips or film of biaxial expanded polytetrafluoroethylene material 10 on the inside surface 14, outside surface 18, inside surface 14 and outside surface 18, or between the inside surface 14 and the outside surface 18 of the discontinuous wall of a stent 12 (FIGS. 7-13). The stent 12 and expanded polytetrafluoroethylene covering 10′ may be bonded together, for instance under heat and pressure, to form the expandable stent-graft 20. Another method of bonding may include the use of another polymer such as a polyurethane or FEP which has a lower melt point.
The expandable stent-graft 20 of the present invention offers the properties of a stent 12 and the benefits of an expanded polytetrafluoroethylene covering that conforms to the compliance and distortion of the underlying stent 12. The expanded polytetrafluoroethylene microstructure (FIGS. 1-3) and it's orientation on the stent 12 (FIGS. 5-13) relate to the present invention. The expandable stent-graft 20 has characteristics that may reduce the occlusion of the lumen and improve healing of the damaged body vessels.
Another preferred embodiment of the expandable stent-graft 20 of the present invention may comprise a uniaxial, expanded polytetrafluoroethylene covering on at least part of the inside surface 14, outside surface 18, inside surface 14 and outside surface 18 or between the inside surface 14 and the outside surface 18 of the stent 12. The uniaxial, expanded polytetrafluoroethylene covering may be comprised substantially of fibrils as the nodules have been reduced substantially to zero. Other uniaxial, expanded polytetrafluoroethylene coverings may have discrete nodules so that the nodules are substantially unconnected to one another.
Another preferred embodiment of the expandable stent-graft 20 of the present invention may comprise a uniaxial, expanded polytetrafluoroethylene covering and a biaxial, expanded polytetrafluoroethylene covering 10′ on at least part of the inside surface 14, outside surface 18, inside surface 14 and outside surface 18, or between the inside surface 14 and the outside surface 18 of the stent 12. The uniaxial, expanded polytetrafluoroethylene covering is comprised substantially of fibrils and is longitudinally oriented on the stent.
In these preferred embodiments, the expanded polytetrafluoroethylene covering may correspondingly expand and contract with the stent 12. As radial and longitudinal forces are applied to the expandable stent-graft (FIG. 13), the nodule and fibril relationship may change within the biaxial expanded polytetrafluoroethylene material 10′ and the fibril relationship within the uniaxial expanded polytetrafluoroethylene material and allows the covering to conform to the shape to of the stent 12. FIG. 13 illustrates an expandable stent-graft of the present invention with the end portions in at least partially radially expanded states and the mid-section in an at least partially radially contracted state.
In the preferred embodiments of the expandable stent-graft 20 of the present invention, the preferred nodule and fibril relationship of the biaxial, expanded polytetrafluoroethylene or the preferred fibril relationship of the uniaxial expanded polytetrafluoroethylene material is dependent on the dimensions of the stent 12 being covered. However, the preferred nodule and fibril relationship of the biaxial, expanded polytetrafluoroethylene in the free state or the preferred fibril relationship of the uniaxial, expanded polytetrafluoroethylene in the free state may have a circumferential fibril length ranging from about 5 microns to about 150 microns; an inter-nodule distance measured in the circumferential direction ranging from about 5 microns to about 150 microns; a longitudinal fibril length ranging from about 5 microns to about 100 microns; or an inter-nodule distance measured in the longitudinal direction ranging from about 5 microns to about 100 microns to be sufficient to offer the desired range of performance for the present invention.
The nodules 2 and fibrils 4, 4′ within the biaxial, expanded polytetrafluoroethylene material may be oriented onto the stent 12 so that the longitudinal fibrils are at least substantially extended 4′ to adapt to the stent 12 longitudinal expansion when the stent 12 is radially compressed; the circumferential fibrils are at least substantially folded 6′ to adapt to the stent radial compression when the stent 12 is longitudinally expanded; the longitudinal fibrils are at least substantially folded 4 to adapt to the stent 12 longitudinal compression when the stent 12 is radially expanded; or the circumferential fibrils are at least substantially extended 6 to adapt to the stent radial expansion when the stent 12 is longitudinally compressed (FIGS. 6, 7, 10, and 13). The interaction of the nodules 2 and fibrils 4, 4′ within the biaxial, expanded polytetrafluoroethylene material 10′ allows the biaxial, expanded polytetrafluoroethylene material 10′ to substantially conform to the radial and longitudinal expansion and compression of the stent 12.
The present invention also relates to a method of bonding an expanded polytetrafluoroethylene material 10, 10′ onto a stent 12 so that the inter-nodule distance measured in the longitudinal direction between nodules is increased when the expandable stent-graft 20 is radially compressed; the inter-nodule distance measured in the longitudinal direction between nodules is decreased when the expandable stent-graft 20 is radially expanded; the inter-nodule distance measured in the circumferential direction between nodules 2 is increased when the expandable stent-graft 20 is longitudinally compressed; or the inter-nodule distance measured in the circumferential direction between nodules 2 is decreased when the expandable stent-graft is longitudinally expanded.
The stent 12 and expanded polytetrafluoroethylene covering 10′ substantially are bonded together and substantially coextensively compress, expand or conform in shape, when radial and longitudinal forces expand or compress the expandable stent-graft 20. For example, the expandable stent-graft 20 may compress when inserted into a delivery catheter or the expandable stent-graft 20 may expand when deployed from the catheter into a body vessel.
The biaxial, expanded polytetrafluoroethylene 10, 10′ or uniaxial, expanded polytetrafluoroethylene covering are not elastomers, yet, they each expand and contract with the radial or longitudinal expansion and compression forces on the expandable stent-graft 20. Also, the biaxial expanded polytetrafluoroethylene or uniaxial expanded polytetrafluoroethylene coverings may expand and compress on the expandable stent-graft 20 and have reduced folds, flaps, pillowing or kinks, thus, reducing the thrombogenic effect that may result from uneven or rough to vessel surfaces. The orientation of the ePTFE and the interaction of the nodules 2 and fibrils 4, 4′, 6, 6′ may allow the inside surface 14 and/or the outside surface 18 to be substantially smooth in both contracted and expanded states.
Another preferred embodiment of the expandable stent-graft 20 of the present invention offers a substantially smooth covering during the radial and longitudinal compression and expansion of the expandable stent-graft 20. Radial compression and longitudinal expansion of the expandable stent-graft 20 occurs when the expandable stent-graft 20 is inserted into a catheter. Radial expansion and longitudinal compression of the expandable stent-graft 20 occurs when the expandable stent-graft 20 is deployed into various sized body vessels.
The expandable stent-graft 20 of the present invention may provide a surface that promotes increased fluid flow, reduced fluid turbulence, and overall improved compliance properties when compared to conventional covered stents. Many of the present invention characteristics are desired by medical practitioners, when repairing and healing body vessels.
When compared to an uncovered stent 12, the expanded polytetrafluoroethylene covering on the stent 12 requires little additional force to expand or contract. The biaxial, expanded polytetrafluoroethylene material 10′ or uniaxial expanded polytetrafluoroethylene material substantially adapts to the radial and longitudinal expansion and compression of the stent 12. The expanded polytetrafluoroethylene covering is intended to enhance the benefits of a conventional stent 12 by adding graft capabilities, without, reducing the compliance or performance of the expandable stent-graft 20.
The expandable stent-graft 20 is generally made in the shape of a cylindrical lumen having a discontinuous wall covered with expanded polytetrafluoroethylene.
A preferred embodiment of the expandable stent-graft of the present invention has a nodule and fibril relationship in the biaxial, expanded polytetrafluoroethylene covering 10′ or a fibril relationship in the uniaxial, expanded polytetrafluoroethylene covering, respectively, such that the expandable stent-graft 20 expands longitudinally up to about 300% when radially compressed as compared to it's length when in a radially expanded state.
Another preferred embodiment of the expandable stent-graft 20 of the present invention has a nodule and fibril relationship in the biaxial, expanded polytetrafluoroethylene covering 10′ or a fibril relationship in the uniaxial, expanded polytetrafluoroethylene covering such that the expandable stent-graft 20 expands radially up to about 1000% of its fully radially compressed diameter measurement.
Another preferred embodiments of the expandable stent-graft 20 of the present invention may comprise at least one partial layer of biaxial, expanded polytetrafluoroethylene or a uniaxial 10′, expanded polytetrafluoroethylene or a combination of a biaxial, expanded polytetrafluoroethylene 10′ and a uniaxial, expanded polytetrafluoroethylene material. The uniaxial, expanded polytetrafluoroethylene material has a fibril relationship and is comprised substantially of fibrils as the nodules 2 have been reduced essentially to nearly zero. Each layer of biaxial or uniaxial, expanded polytetrafluoroethylene material may have a thickness ranging from about 10 to about 500 microns and may be made from tube, sheet, film or a plurality of strips disposed on the inner surface 14 of the discontinuous wall, outer surface 18 of the discontinuous wall, both the inner surface 14 and outer surface 18 of the discontinuous wall of the stent or between the inner surface 14 and outer surface 18 of the discontinuous wall of the stent 12 including the voids between the mesh of the walls. The discontinuous wall and the expanded polytetrafluoroethylene material are bonded at a temperature range of about 340° C. to about 390° C.
In a further embodiment of the expandable stent-graft 20 of the present invention, the discontinuous wall of the stent 12 may be coated with expanded polytetrafluoroethylene, polytetrafluoroethylene or both expanded polytetrafluoroethylene and polytetrafluoroethylene on at least part of its surface.
The preferred embodiments of the expandable stent-graft 20 of the present invention, may be produced by the method of placing a biaxial expanded polytetrafluoroethylene material 10 on a mandrel 8 in an at least partially expanded state, and then longitudinally compressing the biaxial, expanded polytetrafluoroethylene material 10 which it is positioned on the mandrel 8 so that the longitudinal fibrils are at least substantially folded 4 and the circumferential fibrils are at least substantially extended 6 or so that the inter-nodule distance measured in the longitudinal direction between nodules 2 is decreased and the inter-nodule distance measured in the circumferential direction between nodules 2 is increased. A stent 12 having an inside diameter greater than the combined diameter of the expanded polytetrafluoroethylene material and the mandrel 8 is then placed onto the outer surface of the expanded polytetrafluoroethylene material. Contact is then maintained between the stent and the expanded polytetrafluoroethylene material while the covering and the stent are heated to a temperature ranging from about 340° C. to about 390° C. for a time ranging from about 1 minute to about 15 minutes to bond the expanded polytetrafluoroethylene material to the discontinuous wall of the stent. The expandable stent-graft is then cooled and removed from the mandrel.
Additionally, the preferred embodiments of the expandable stent-graft of the present invention may also be produced by the method of placing a biaxial expanded polytetrafluoroethylene material on a mandrel and then longitudinally expanding or stretching the biaxial, expanded polytetrafluoroethylene material while it is positioned on the mandrel so that the longitudinal fibrils are at least substantially extended and the circumferential fibrils are at least substantially folded. Also, the inter-nodule distance measured in the longitudinal direction between nodules 2 may be increased and the inter-nodule distance measured in the circumferential direction between nodules 2 may be decreased. A stent having a diameter greater than the combined diameter of the expanded polytetrafluoroethylene material and the mandrel is then placed onto the outer surface of the expanded polytetrafluoroethylene material. The expandable stent-graft is radially compressed and contact is then maintained between the stent and the expanded polytetrafluoroethylene material while the covering and the stent are heated to a temperature ranging from about 340° C. to about 390° C. for a time ranging from about 1 minute to about 15 minutes to bond the expanded polytetrafluoroethylene material to the discontinuous wall of the stent. The expandable stent-graft is then cooled and removed from the mandrel.
The preferred embodiment of the expandable stent-graft of the present invention may also be produced by longitudinally compressing the expanded polytetrafluoroethylene material, prior to the step of placing the expanded polytetrafluoroethylene material on the mandrel.
The preferred embodiment of the expandable stent-graft of the present invention may also be produced by longitudinally expanding or stretching the expanded polytetrafluoroethylene material prior to the step of placing the expanded polytetrafluoroethylene material on the mandrel. An expanded polytetrafluoroethylene tape can be diagonally wound under tension about an at least partially expanded stent. Additional compressible and expandable objects of varying size, shape, compliance or dimension may also be able to take advantage of the expanded polytetrafluoroethylene coverings.
This invention has been described herein in considerable detail to comply with the Patent Statutes and to provide those skilled in the art with the information needed to apply the novel principles and to construct and use such specialized components as are required. However, it is to be understood that the invention can be carried out by specifically different equipment and devices, and that various modifications, both as to the equipment details and procedures, can be accomplished without departing from the scope of the invention itself. Therefore, the spirit and scope of the claims should not be limited to the description of the preferred versions contained herein.

Claims (19)

1. An expandable stent-graft comprising:
(a) a braided self-expanding stent characterized by a longitudinal shortening upon radial expansion from a first longitudinal stent length to a second longitudinal stent length; and
(b) a least one tubular layer of biaxially oriented expanded polytetrafluoroethylene comprising nodules and fibrils affixed to the stent characterized by a shortening of average longitudinal inter-nodule distance upon radial expansion from a first average longitudinal inter-nodule distance to a second average longitudinal inter-nodule distance and having (i) a first average longitudinal inter-nodule distance of between about 50 and about 150 microns, and (ii) a second average longitudinal inter-nodule distance of between about 0 and about 50 microns;
wherein the ratio of first longitudinal stent length to second longitudinal stent length is within about 25 percent of the ratio of first average longitudinal inter-nodule distance to a second average inter-nodule distance.
2. The expandable stent-graft according to claim 1 wherein the tubular layer of expanded polytetrafluoroethylene has a second average longitudinal inter-nodule distance of between about 5 and about 45 microns.
3. The expandable stent-graft according to claim 2 wherein the tubular layer of expanded polytetrafluoroethylene has a second average longitudinal inter-nodule distance of between about 20 and about 30 microns.
4. The expandable stent-graft according to claim 1 wherein the tubular layer of expanded polytetrafluoroethylene has a first average longitudinal inter-nodule distance of between about 60 and about 140 microns.
5. The expandable stent-graft according to claim 4 herein the tubular layer of expanded polytetrafluoroethylene has a first average longitudinal inter-nodule distance of between about 80 and about 120 microns.
6. An expandable stent-graft comprising:
(a) a braided self-expanding stent having a first longitudinal stent length in an expanded position and a second longitudinal stent length in a contracted position; and
(b) at least one tubular layer of expanded polytetrafluoroethylene comprising nodules and fibrils affixed to the stent,
wherein the expanded polytetrafluoroethylene layer has an average longitudinal inter-nodule distance of between about 50 and about 150 microns when the stent is in an expanded position and an average longitudinal inter-nodule distance of between about 0 and about 50 microns when the stent is in a longitudinally contracted position, and wherein the average longitudinal inter-nodule distance shortens from a first average longitudinal inter-nodule distance to a second average longitudinal inter-nodule distance upon radial expansion.
7. The stent-graft of claim 6 , wherein the ratio of first longitudinal stent length to second longitudinal stent length is within about 25 percent of the ratio of a first average longitudinal inter-nodule distance to a second average inter-nodule distance.
8. The stent-graft of claim 6 , wherein the fibrils are substantially folded when the stent is in a contracted position and substantially extended when the stent is in an expanded position.
9. The stent-graft of claim 6 , wherein the expanded polytetrafluoroethylene is biaxially oriented.
10. The stent-graft of claim 6 , wherein the expanded polytetrafluoroethylene has an average longitudinal inter-nodal distance of between about 5 and about 45 microns.
11. The stent-graft of claim 6 , wherein the expanded polytetrafluoroethylene has an average longitudinal inter-nodal distance of between about 20 and about 30 microns.
12. The stent-graft of claim 6 , wherein the expanded polytetrafluoroethylene has an average longitudinal inter-nodal distance of between about 60 and about 140 microns.
13. The stent-graft of claim 6 , wherein the expanded polytetrafluoroethylene has an average longitudinal inter-nodal distance of between about 80 and about 120 microns.
14. An expandable prosthesis comprising:
(a) a discontinuous wall having a first longitudinal wall length in an expanded position and a second longitudinal wall length in a contracted position; and
(b) at least one tubular layer of expanded polytetrafluoroethylene comprising nodules and fibrils,
wherein the expanded polytetrafluoroethylene layer has an average longitudinal inter-nodule distance of between about 50 and about 150 microns when the discontinuous wall is in a longitudinally expanded position and an average longitudinal inter-nodule distance of between about 0 and about 50 microns when the discontinuous wall is in a longitudinally contracted position, wherein the average longitudinal inter-nodule distance shortens from a first average inter-nodule distance to a second average longitudinal distance upon radial expansion; and wherein the ratio of first longitudinal wall length to second longitudinal wall length is within about 25 percent of the ratio of a first average longitudinal inter-nodule distance to a second average inter-nodule distance.
15. An expandable stent-graft comprising:
(a) a braided self-expanding stent having a first longitudinal stent length in an expanded position and a second longitudinal stent length in a contracted position; and
(b) at least one tubular layer of expanded polytetrafluoroethylene comprising nodules and fibrils affixed to the stent,
wherein the expanded polytetrafluoroethylene layer has an average first inter-nodule distance of between about 50 and about 150 microns when the stent is in an expanded position and an average longitudinal inter-nodule distance of between about 0 and about 50 microns when the stent is in a longitudinally contracted position, and wherein the ratio of the first longitudinal stent length to the second longitudinal stent length is within about 25 percent of the ratio of a first average longitudinal inter-nodule distance to a second average inter-nodule distance.
16. An expandable prosthesis comprising:
(a) a discontinuous wall having a first longitudinal wall length in an expanded position and a second longitudinal wall length in a contracted position; and
(b) at least one tubular layer of expanded polytetrafluoroethylene comprising nodules and fibrils affixed to the wall;
wherein the expanded polytetrafluoroethylene layer has an average inter-nodule distance of between about 50 and about 150 microns when the wall is in an expanded position and an average longitudinal inter-nodule distance of between about 0 and about 50 microns when the wall is in a longitudinally contracted position, and wherein the ratio of the first longitudinal wall length to the second longitudinal wall length is within about 25 percent of the ratio of a first average inter-nodule distance to a second average inter-nodule distance.
17. An expandable stent-graft comprising:
(a) a braided self-expanding stent that is capable of longitudinal shortening upon radial expansion from a first longitudinal stent length to a second longitudinal stent length; and
(b) at least one layer of expanded polytetrafluoroethylene defining spaced-apart nodes interconnected by longitudinally directed fibrils, said nodes having a first average longitudinal inter-nodule distance in a free state, the layer of polytetrafluoroethylene affixed to the stent such that it has a second average longitudinal inter-nodule distance when the stent is in a longitudinally contracted state, the second average longitudinal inter-nodule distance being less than the first average longitudinal inter-nodule distance, said longitudinally directed fibrils being extended in said free state and being folded in said longitudinally contracted state.
18. An expandable stent-graft comprising:
(a) a braided self-expanding stent that is capable of longitudinal shortening upon radial expansion;
(b) at least one layer of expanded polytetrafluoroethylene comprising spaced apart nodes interconnected by fibrils,
wherein the fibrils are extended when the layer is in a free state and folded in a contracted state, said fibrils defining openings of between about 50 to about 150 microns when the layer is in the free state and openings of about 0 to about 50 microns when the layer is in the contracted state.
19. An expandable prosthesis comprising:
(a) a discontinuous wall defining a lumen adapted to assume a longitudinally contracted position and a longitudinally expanded position; and
(b) at least one layer of expanded polytetrafluoroethylene comprising spaced apart nodes interconnected by fibrils,
wherein the fibrils are extended when the discontinuous wall is in an expanded position and folded when the discontinuous wall is in a contracted position, said fibrils defining openings of between about 50 to about 150 microns when the wall is in a longitudinally expanded position and openings of between about 0 to about 50 microns when the wall is in a longitudinally contracted position.
US11/067,620 1995-11-21 2005-02-25 Expandable stent-graft covered with expanded polytetrafluoroethylene Expired - Lifetime USRE40122E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/067,620 USRE40122E1 (en) 1995-11-21 2005-02-25 Expandable stent-graft covered with expanded polytetrafluoroethylene

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US743595P 1995-11-21 1995-11-21
US08/751,884 US5788626A (en) 1995-11-21 1996-11-18 Method of making a stent-graft covered with expanded polytetrafluoroethylene
US08/988,725 US6165211A (en) 1995-11-21 1997-12-11 Expandable stent-graft covered with expanded polytetrafluoroethylene
US09/556,726 US6524334B1 (en) 1995-11-21 2000-04-21 Expandable stent-graft covered with expanded polytetrafluoroethylene
US11/067,620 USRE40122E1 (en) 1995-11-21 2005-02-25 Expandable stent-graft covered with expanded polytetrafluoroethylene

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/556,726 Reissue US6524334B1 (en) 1995-11-21 2000-04-21 Expandable stent-graft covered with expanded polytetrafluoroethylene

Publications (1)

Publication Number Publication Date
USRE40122E1 true USRE40122E1 (en) 2008-02-26

Family

ID=21726137

Family Applications (4)

Application Number Title Priority Date Filing Date
US08/751,884 Expired - Lifetime US5788626A (en) 1995-11-21 1996-11-18 Method of making a stent-graft covered with expanded polytetrafluoroethylene
US08/988,725 Expired - Lifetime US6165211A (en) 1995-11-21 1997-12-11 Expandable stent-graft covered with expanded polytetrafluoroethylene
US09/556,726 Ceased US6524334B1 (en) 1995-11-21 2000-04-21 Expandable stent-graft covered with expanded polytetrafluoroethylene
US11/067,620 Expired - Lifetime USRE40122E1 (en) 1995-11-21 2005-02-25 Expandable stent-graft covered with expanded polytetrafluoroethylene

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US08/751,884 Expired - Lifetime US5788626A (en) 1995-11-21 1996-11-18 Method of making a stent-graft covered with expanded polytetrafluoroethylene
US08/988,725 Expired - Lifetime US6165211A (en) 1995-11-21 1997-12-11 Expandable stent-graft covered with expanded polytetrafluoroethylene
US09/556,726 Ceased US6524334B1 (en) 1995-11-21 2000-04-21 Expandable stent-graft covered with expanded polytetrafluoroethylene

Country Status (7)

Country Link
US (4) US5788626A (en)
EP (2) EP1530956B1 (en)
JP (3) JP3414956B2 (en)
AT (2) ATE288715T1 (en)
AU (1) AU714991B2 (en)
CA (1) CA2190717C (en)
DE (1) DE69634325T2 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050216043A1 (en) * 2004-03-26 2005-09-29 Blatter Duane D Stented end graft vessel device for anastomosis and related methods for percutaneous placement
US20070088425A1 (en) * 2005-10-13 2007-04-19 Cook Incorporated Endoluminal prosthesis
US20070178129A1 (en) * 2006-02-01 2007-08-02 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20080071351A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Endoprosthesis with adjustable surface features
US20080071348A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Medical Devices
US20080071353A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Endoprosthesis containing magnetic induction particles
US20080071358A1 (en) * 2006-09-18 2008-03-20 Boston Scientific Scimed, Inc. Endoprostheses
US20080097577A1 (en) * 2006-10-20 2008-04-24 Boston Scientific Scimed, Inc. Medical device hydrogen surface treatment by electrochemical reduction
US20090076587A1 (en) * 2007-09-13 2009-03-19 Cully Edward H Stented Vascular Graft
US20090292352A1 (en) * 2002-06-27 2009-11-26 Boston Scientific Scimed, Inc. Methods of making medical devices
US20090306765A1 (en) * 2008-06-10 2009-12-10 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
US20110118826A1 (en) * 2008-07-30 2011-05-19 Boston Scientific Scimed. Inc. Bioerodible Endoprosthesis
US20110160839A1 (en) * 2009-12-29 2011-06-30 Boston Scientific Scimed, Inc. Endoprosthesis
US20110190870A1 (en) * 2009-12-30 2011-08-04 Boston Scientific Scimed, Inc. Covered Stent for Vascular Closure
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8052744B2 (en) 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8057534B2 (en) 2006-09-15 2011-11-15 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8080055B2 (en) 2006-12-28 2011-12-20 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8128689B2 (en) 2006-09-15 2012-03-06 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis with biostable inorganic layers
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8303643B2 (en) 2001-06-27 2012-11-06 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same

Families Citing this family (217)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
US6451047B2 (en) * 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US6579314B1 (en) * 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
AU707727B2 (en) * 1995-08-24 1999-07-15 Impra, Inc. Covered endoluminal stent and method of assembly
US5788626A (en) 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US5800512A (en) * 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US5747128A (en) * 1996-01-29 1998-05-05 W. L. Gore & Associates, Inc. Radially supported polytetrafluoroethylene vascular graft
ES2159862T3 (en) * 1996-03-29 2001-10-16 Ruesch Willy Ag EXTENSIONER
ATE309762T1 (en) * 1996-09-26 2005-12-15 Scimed Life Systems Inc COMBINED MEDICAL DEVICE CONSISTING OF A SUPPORT STRUCTURE AND A MEMBRANE
US6315791B1 (en) 1996-12-03 2001-11-13 Atrium Medical Corporation Self-expanding prothesis
US5925074A (en) * 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
IT1289815B1 (en) * 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS
US5961545A (en) * 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
CA2424551A1 (en) 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
US5980564A (en) * 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
US6245103B1 (en) 1997-08-01 2001-06-12 Schneider (Usa) Inc Bioabsorbable self-expanding stent
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6488701B1 (en) 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
DE19819629A1 (en) * 1998-05-04 1999-11-11 Jomed Implantate Gmbh Radially expandable stent
US6497722B1 (en) 1998-05-04 2002-12-24 Jomed Gmbh Methods and apparatus for in-vivo tailored stents indicated for use in tortuous anatomy
ATE358456T1 (en) * 1998-05-05 2007-04-15 Boston Scient Ltd STENT WITH SMOOTH ENDS
US6352554B2 (en) * 1998-05-08 2002-03-05 Sulzer Vascutek Limited Prosthetic tubular aortic conduit and method for manufacturing the same
US6099559A (en) * 1998-05-28 2000-08-08 Medtronic Ave, Inc. Endoluminal support assembly with capped ends
US6156064A (en) * 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US6143022A (en) * 1998-08-24 2000-11-07 Medtronic Ave, Inc. Stent-graft assembly with dual configuration graft component and method of manufacture
US6746489B2 (en) 1998-08-31 2004-06-08 Wilson-Cook Medical Incorporated Prosthesis having a sleeve valve
US6206915B1 (en) * 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
US6168619B1 (en) 1998-10-16 2001-01-02 Quanam Medical Corporation Intravascular stent having a coaxial polymer member and end sleeves
US6261255B1 (en) 1998-11-06 2001-07-17 Ronald Jay Mullis Apparatus for vascular access for chronic hemodialysis
US20010049554A1 (en) * 1998-11-18 2001-12-06 Carlos E. Ruiz Endovascular prosthesis and method of making
US20040267349A1 (en) * 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
US20060178727A1 (en) * 1998-12-03 2006-08-10 Jacob Richter Hybrid amorphous metal alloy stent
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US6165140A (en) 1998-12-28 2000-12-26 Micrus Corporation Composite guidewire
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6364903B2 (en) * 1999-03-19 2002-04-02 Meadox Medicals, Inc. Polymer coated stent
US6352531B1 (en) 1999-03-24 2002-03-05 Micrus Corporation Variable stiffness optical fiber shaft
US6887235B2 (en) 1999-03-24 2005-05-03 Micrus Corporation Variable stiffness heating catheter
US6689160B1 (en) 1999-05-31 2004-02-10 Sumitomo Electric Industries, Ltd. Prosthesis for blood vessel
US6342294B1 (en) * 1999-08-12 2002-01-29 Bruce G. Ruefer Composite PTFE article and method of manufacture
US6334868B1 (en) 1999-10-08 2002-01-01 Advanced Cardiovascular Systems, Inc. Stent cover
SE515231C2 (en) * 1999-10-13 2001-07-02 Jan Otto Solem Covered stent and way to manufacture the same
US6325823B1 (en) 1999-10-29 2001-12-04 Revasc Corporation Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use
US6264671B1 (en) * 1999-11-15 2001-07-24 Advanced Cardiovascular Systems, Inc. Stent delivery catheter and method of use
US7736687B2 (en) 2006-01-31 2010-06-15 Advance Bio Prosthetic Surfaces, Ltd. Methods of making medical devices
US6537310B1 (en) 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US10172730B2 (en) 1999-11-19 2019-01-08 Vactronix Scientific, Llc Stents with metallic covers and methods of making same
US6602224B1 (en) 1999-12-22 2003-08-05 Advanced Cardiovascular Systems, Inc. Medical device formed of ultrahigh molecular weight polyolefin
US6428506B1 (en) 1999-12-22 2002-08-06 Advanced Cardiovascular Systems, Inc. Medical device formed of ultrahigh molecular weight polyethylene
US6296661B1 (en) 2000-02-01 2001-10-02 Luis A. Davila Self-expanding stent-graft
US6245100B1 (en) 2000-02-01 2001-06-12 Cordis Corporation Method for making a self-expanding stent-graft
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6613082B2 (en) 2000-03-13 2003-09-02 Jun Yang Stent having cover with drug delivery capability
US6808533B1 (en) 2000-07-28 2004-10-26 Atrium Medical Corporation Covered stent and method of covering a stent
US7118592B1 (en) 2000-09-12 2006-10-10 Advanced Cardiovascular Systems, Inc. Covered stent assembly for reduced-shortening during stent expansion
US6695833B1 (en) * 2000-09-27 2004-02-24 Nellix, Inc. Vascular stent-graft apparatus and forming method
US6652574B1 (en) * 2000-09-28 2003-11-25 Vascular Concepts Holdings Limited Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer
US6923927B2 (en) * 2000-10-03 2005-08-02 Atrium Medical Corporation Method for forming expandable polymers having drugs or agents included therewith
US6616876B1 (en) 2000-10-03 2003-09-09 Atrium Medical Corporation Method for treating expandable polymer materials
US6770086B1 (en) 2000-11-02 2004-08-03 Scimed Life Systems, Inc. Stent covering formed of porous polytetraflouroethylene
US6641607B1 (en) 2000-12-29 2003-11-04 Advanced Cardiovascular Systems, Inc. Double tube stent
EP1372531A2 (en) * 2001-03-30 2004-01-02 Terumo Kabushiki Kaisha Stent cover and stent
US6673105B1 (en) * 2001-04-02 2004-01-06 Advanced Cardiovascular Systems, Inc. Metal prosthesis coated with expandable ePTFE
US6756007B2 (en) 2001-04-04 2004-06-29 Bard Peripheral Vascular, Inc. Method for preparing an implantable prosthesis for loading into a delivery apparatus
US6911038B2 (en) * 2001-05-08 2005-06-28 Scimed Life Systems, Inc. Matched balloon to stent shortening
US6605154B1 (en) * 2001-05-31 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent mounting device
US6887215B2 (en) * 2001-06-01 2005-05-03 Boston Scientific Scimed, Inc. Compressible ureteral stent for comfort
US7510571B2 (en) * 2001-06-11 2009-03-31 Boston Scientific, Scimed, Inc. Pleated composite ePTFE/textile hybrid covering
US7560006B2 (en) 2001-06-11 2009-07-14 Boston Scientific Scimed, Inc. Pressure lamination method for forming composite ePTFE/textile and ePTFE/stent/textile prostheses
US6572644B1 (en) * 2001-06-27 2003-06-03 Advanced Cardiovascular Systems, Inc. Stent mounting device and a method of using the same to coat a stent
US6695920B1 (en) 2001-06-27 2004-02-24 Advanced Cardiovascular Systems, Inc. Mandrel for supporting a stent and a method of using the mandrel to coat a stent
US6673154B1 (en) * 2001-06-28 2004-01-06 Advanced Cardiovascular Systems, Inc. Stent mounting device to coat a stent
US6527863B1 (en) 2001-06-29 2003-03-04 Advanced Cardiovascular Systems, Inc. Support device for a stent and a method of using the same to coat a stent
US6716239B2 (en) 2001-07-03 2004-04-06 Scimed Life Systems, Inc. ePTFE graft with axial elongation properties
US20040133260A1 (en) * 2001-07-06 2004-07-08 Schwartz Robert S. Lumenal vascular compliance device and method of use
DE10135315A1 (en) * 2001-07-19 2003-01-30 Bayer Ag stents
US6827737B2 (en) * 2001-09-25 2004-12-07 Scimed Life Systems, Inc. EPTFE covering for endovascular prostheses and method of manufacture
DE60236755D1 (en) * 2001-10-04 2010-07-29 Neovasc Medical Ltd RIVER REDUCING IMPLANT
US6814561B2 (en) * 2001-10-30 2004-11-09 Scimed Life Systems, Inc. Apparatus and method for extrusion of thin-walled tubes
US7597775B2 (en) * 2001-10-30 2009-10-06 Boston Scientific Scimed, Inc. Green fluoropolymer tube and endovascular prosthesis formed using same
US6719784B2 (en) 2001-11-21 2004-04-13 Scimed Life Systems, Inc. Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis
DE10159708A1 (en) * 2001-12-05 2003-06-18 Bayer Ag Alkaline chloride electrolysis cell with gas diffusion electrodes
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7125464B2 (en) 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US6837890B1 (en) 2001-12-26 2005-01-04 Advanced Cardiovascular Systems, Inc. Expanded UHMWPE for guiding catheter liners and other lubricious coatings
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
US20030181810A1 (en) 2002-03-25 2003-09-25 Murphy Kieran P. Kit for image guided surgical procedures
US9375203B2 (en) 2002-03-25 2016-06-28 Kieran Murphy Llc Biopsy needle
US20030204248A1 (en) * 2002-03-25 2003-10-30 Murphy Kieran P. Device viewable under an imaging beam
US7927368B2 (en) * 2002-03-25 2011-04-19 Kieran Murphy Llc Device viewable under an imaging beam
US7288111B1 (en) * 2002-03-26 2007-10-30 Thoratec Corporation Flexible stent and method of making the same
CA2485285A1 (en) * 2002-05-10 2003-11-20 Cordis Corporation Method of making a medical device having a thin wall tubular membrane over a structural frame
US7789908B2 (en) * 2002-06-25 2010-09-07 Boston Scientific Scimed, Inc. Elastomerically impregnated ePTFE to enhance stretch and recovery properties for vascular grafts and coverings
US7147619B2 (en) * 2002-07-22 2006-12-12 Advanced Cardiovascular Systems, Inc. Catheter balloon having impregnated balloon skirt sections
US6902571B2 (en) 2002-08-29 2005-06-07 Advanced Cardiovascular Systems, Inc. Compacted catheter balloon and method of incremental compaction
EP1542616B1 (en) 2002-09-20 2015-04-22 Endologix, Inc. Stent-graft with positioning anchor
US6818063B1 (en) * 2002-09-24 2004-11-16 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and method for minimizing coating defects
US7776381B1 (en) 2002-09-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and method for reducing coating defects
US7335265B1 (en) 2002-10-08 2008-02-26 Advanced Cardiovascular Systems Inc. Apparatus and method for coating stents
US20040102855A1 (en) * 2002-11-21 2004-05-27 Scimed Life Systems, Inc. Anti-reflux stent
US7416609B1 (en) * 2002-11-25 2008-08-26 Advanced Cardiovascular Systems, Inc. Support assembly for a stent
US7074276B1 (en) 2002-12-12 2006-07-11 Advanced Cardiovascular Systems, Inc. Clamp mandrel fixture and a method of using the same to minimize coating defects
US6863757B1 (en) 2002-12-19 2005-03-08 Advanced Cardiovascular Systems, Inc. Method of making an expandable medical device formed of a compacted porous polymeric material
US7628859B1 (en) * 2002-12-27 2009-12-08 Advanced Cardiovascular Systems, Inc. Mounting assembly for a stent and a method of using the same to coat a stent
US7195638B1 (en) * 2002-12-30 2007-03-27 Advanced Cardiovascular Systems, Inc. Catheter balloon
US7147817B1 (en) 2002-12-31 2006-12-12 Advanced Cardiovascular Systems, Inc. Method of making a low profile balloon
US7354480B1 (en) * 2003-02-26 2008-04-08 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and system for reducing coating defects
US7150758B2 (en) * 2003-03-06 2006-12-19 Boston Scientific Santa Rosa Corp. Kink resistant endovascular graft
US7318836B2 (en) 2003-03-11 2008-01-15 Boston Scientific Scimed, Inc. Covered stent
US7323209B1 (en) 2003-05-15 2008-01-29 Advanced Cardiovascular Systems, Inc. Apparatus and method for coating stents
US9155639B2 (en) 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US20050060020A1 (en) * 2003-09-17 2005-03-17 Scimed Life Systems, Inc. Covered stent with biologically active material
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US7448122B1 (en) 2003-10-31 2008-11-11 Advanced Cardiovascular Systems, Inc. Method of compressing a polymeric layer of an expandable medical device
WO2005061023A1 (en) 2003-12-12 2005-07-07 C. R. Bard, Inc. Implantable medical devices with fluorinated polymer coatings, and methods of coating thereof
US8042485B1 (en) 2003-12-30 2011-10-25 Advanced Cardiovascular Systems, Inc. Stent mandrel fixture and method for coating stents
US7530994B2 (en) 2003-12-30 2009-05-12 Scimed Life Systems, Inc. Non-porous graft with fastening elements
US7418464B2 (en) * 2004-01-27 2008-08-26 International Business Machines Corporation Method, system, and program for storing data for retrieval and transfer
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
CN1921905A (en) * 2004-02-27 2007-02-28 住友电气工业株式会社 Composite structural body and its preparing method
AU2005218677B2 (en) * 2004-03-02 2011-11-03 Peter William Walsh A vessel or sac wall treatment and a cardiac assist device
US8349388B1 (en) 2004-03-18 2013-01-08 Advanced Cardiovascular Systems, Inc. Method of coating a stent
US7727271B2 (en) * 2004-06-24 2010-06-01 Boston Scientific Scimed, Inc. Implantable prosthesis having reinforced attachment sites
US7955373B2 (en) * 2004-06-28 2011-06-07 Boston Scientific Scimed, Inc. Two-stage stent-graft and method of delivering same
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
WO2006024488A2 (en) 2004-08-30 2006-03-09 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US8029563B2 (en) 2004-11-29 2011-10-04 Gore Enterprise Holdings, Inc. Implantable devices with reduced needle puncture site leakage
US7892592B1 (en) 2004-11-30 2011-02-22 Advanced Cardiovascular Systems, Inc. Coating abluminal surfaces of stents and other implantable medical devices
US20060233990A1 (en) * 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US20060233991A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
CA2608160C (en) 2005-05-09 2013-12-03 Jurgen Dorn Implant delivery device
CA2843097C (en) * 2005-05-24 2015-10-27 Inspire M.D Ltd. Stent apparatuses for treatment via body lumens and methods of use
US7622070B2 (en) * 2005-06-20 2009-11-24 Advanced Cardiovascular Systems, Inc. Method of manufacturing an implantable polymeric medical device
US7823533B2 (en) 2005-06-30 2010-11-02 Advanced Cardiovascular Systems, Inc. Stent fixture and method for reducing coating defects
US7666220B2 (en) 2005-07-07 2010-02-23 Nellix, Inc. System and methods for endovascular aneurysm treatment
DE102005032308A1 (en) * 2005-07-11 2007-01-18 Campus Gmbh & Co. Kg Endovascular implant for the occlusion of a blood vessel
US7735449B1 (en) 2005-07-28 2010-06-15 Advanced Cardiovascular Systems, Inc. Stent fixture having rounded support structures and method for use thereof
CN1911188B (en) * 2005-08-09 2010-10-13 微创医疗器械(上海)有限公司 Stent prosthesis used for surgical operation, and delivery device therefor
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US20070160672A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast films
US20070158880A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast tubes
US20070162110A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices
US8900287B2 (en) * 2006-01-13 2014-12-02 Aga Medical Corporation Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm
US20070179599A1 (en) * 2006-01-31 2007-08-02 Icon Medical Corp. Vascular protective device
US8025693B2 (en) * 2006-03-01 2011-09-27 Boston Scientific Scimed, Inc. Stent-graft having flexible geometries and methods of producing the same
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8003156B2 (en) 2006-05-04 2011-08-23 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
EP2023869B1 (en) * 2006-05-12 2019-09-18 Cardinal Health Switzerland 515 GmbH Balloon expandable bioabsorbable drug eluting flexible stent
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
EP2059189A4 (en) 2006-08-29 2013-07-10 Bard Inc C R Helical high fatigue stent-graft
WO2008033678A2 (en) * 2006-09-14 2008-03-20 C. R. Bard, Inc. Compressed inner covering hinged segmented stent-graft
WO2008036548A2 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
US10188534B2 (en) * 2006-11-17 2019-01-29 Covidien Lp Stent having reduced passage of emboli and stent delivery system
KR100847123B1 (en) * 2006-11-22 2008-07-18 주식회사 스텐다드싸이텍 Stent
US8221505B2 (en) 2007-02-22 2012-07-17 Cook Medical Technologies Llc Prosthesis having a sleeve valve
US8646444B2 (en) * 2007-03-27 2014-02-11 Electrolux Home Products, Inc. Glide rack
US8087923B1 (en) 2007-05-18 2012-01-03 C. R. Bard, Inc. Extremely thin-walled ePTFE
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
WO2009046372A2 (en) 2007-10-04 2009-04-09 Trivascular2, Inc. Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8601853B2 (en) * 2007-12-18 2013-12-10 Abbott Laboratories Method and apparatus for reducing the size of an endoprosthesis
US7972373B2 (en) * 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US8196279B2 (en) 2008-02-27 2012-06-12 C. R. Bard, Inc. Stent-graft covering process
CN101902988A (en) 2008-04-25 2010-12-01 耐利克斯股份有限公司 The induction system of stent graft
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
CA2726596A1 (en) 2008-06-04 2009-12-10 Nellix, Inc. Sealing apparatus and methods of use
CA2739279C (en) 2008-10-03 2017-07-25 C.R. Bard, Inc. Implantable prosthesis
US20130268062A1 (en) 2012-04-05 2013-10-10 Zeus Industrial Products, Inc. Composite prosthetic devices
US8257640B2 (en) 2009-08-07 2012-09-04 Zeus Industrial Products, Inc. Multilayered composite structure with electrospun layer
WO2011031364A1 (en) * 2009-09-14 2011-03-17 Circulite, Inc Endovascular anastomotic connector device, delivery system, and methods of delivery and use
US8333727B2 (en) * 2009-10-08 2012-12-18 Circulite, Inc. Two piece endovascular anastomotic connector
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
US9750866B2 (en) 2010-02-11 2017-09-05 Circulite, Inc. Cannula lined with tissue in-growth material
CA2787632C (en) * 2010-02-11 2017-05-16 Circulite, Inc. Cannula lined with tissue in-growth material and method of using the same
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
WO2012139054A1 (en) 2011-04-06 2012-10-11 Endologix, Inc. Method and system for endovascular aneurysm treatment
US9060852B2 (en) * 2011-04-08 2015-06-23 Cook Medical Technologies Llc Method for making a flexible stent-graft
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
JP6220386B2 (en) 2012-05-14 2017-10-25 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Uniformly expandable stent
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
EP2968692B8 (en) 2013-03-14 2021-02-24 Endologix LLC Method for forming materials in situ within a medical device
US9522072B2 (en) * 2013-03-15 2016-12-20 W. L. Gore & Associates, Inc. Porous materials having a fibrillar microstructure and a fracturable coating
US10905539B2 (en) 2013-03-15 2021-02-02 W. L. Gore & Associates, Inc. Self-expanding, balloon expandable stent-grafts
US10842918B2 (en) * 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
US9814560B2 (en) 2013-12-05 2017-11-14 W. L. Gore & Associates, Inc. Tapered implantable device and methods for making such devices
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
JP6673942B2 (en) 2015-06-05 2020-04-01 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated Tapered hypobleeding implantable prosthesis
EP4233806A3 (en) 2016-04-21 2023-09-06 W. L. Gore & Associates, Inc. Diametrically adjustable endoprostheses
EP3687451B1 (en) 2017-09-27 2023-12-13 Edwards Lifesciences Corporation Prosthetic valve with expandable frame
WO2019089136A1 (en) 2017-10-31 2019-05-09 W. L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
EP3801310A1 (en) 2018-06-11 2021-04-14 Boston Scientific Scimed Inc. Sphincterotomes and methods for using sphincterotomes
CA3127324A1 (en) 2019-01-23 2020-07-30 Neovasc Medical Ltd. Covered flow modifying apparatus
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element

Citations (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953566A (en) 1970-05-21 1976-04-27 W. L. Gore & Associates, Inc. Process for producing porous products
US4482516A (en) 1982-09-10 1984-11-13 W. L. Gore & Associates, Inc. Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure
US4655771A (en) 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
WO1987004935A1 (en) 1986-02-24 1987-08-27 Fischell Robert An intravascular stent and percutaneous insertion system
US4850999A (en) 1980-05-24 1989-07-25 Institute Fur Textil-Und Faserforschung Of Stuttgart Flexible hollow organ
DE3918736A1 (en) 1989-06-08 1990-12-13 Christian Dr Vallbracht PTFE coating for metal mesh prosthesis used in artery expansion - internal and external coatings are applied to mesh and prevent thrombosis and further arterial restriction
US5061275A (en) 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5112900A (en) 1990-11-28 1992-05-12 Tactyl Technologies, Inc. Elastomeric triblock copolymer compositions and articles made therewith
US5123917A (en) 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5147385A (en) 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5221261A (en) 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
EP0551179A1 (en) 1992-01-08 1993-07-14 Expandable Grafts Partnership Method and apparatus for bilateral intra-aortic bypass
US5234456A (en) 1990-02-08 1993-08-10 Pfizer Hospital Products Group, Inc. Hydrophilic stent
US5269755A (en) * 1992-09-11 1993-12-14 Sherwood Medical Company Catheter with outer membrane medicament delivery system
US5282824A (en) 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5308664A (en) * 1987-10-19 1994-05-03 W. L. Gore & Associates, Inc. Rapidly recoverable PTFE and process therefore
EP0621015A1 (en) 1993-04-23 1994-10-26 Schneider (Europe) Ag Stent with a covering layer of elastic material and methods for applying the layer on the stent
WO1995005555A1 (en) 1993-08-18 1995-02-23 W. L. Gore & Associates, Inc. A thin-wall polytetrafluoroethylene tube
WO1995005132A1 (en) 1993-08-18 1995-02-23 W.L. Gore & Associates, Inc. An intraluminal stent graft
WO1995005131A1 (en) 1993-08-18 1995-02-23 W.L. Gore & Associates, Inc. A tubular intraluminal graft
US5443909A (en) * 1991-12-06 1995-08-22 Kanzaki Paper Manufacturing Co., Ltd. Microcapsule containing ultraviolet absorber
US5466252A (en) * 1992-10-02 1995-11-14 W. L. Gore & Associates, Inc. Implantable lead
WO1996000103A1 (en) 1994-06-27 1996-01-04 Endomed, Inc. Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith
WO1996028115A1 (en) 1995-03-10 1996-09-19 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
WO1996040001A1 (en) 1995-06-07 1996-12-19 Baxter International Inc. Externally supported tape reinforced vascular graft
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5607478A (en) 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US5607468A (en) 1994-11-04 1997-03-04 Aeroquip Corporation Method of manufacturing an intraluminal stenting graft
WO1997007751A1 (en) 1995-08-24 1997-03-06 Impra, Inc. Covered endoluminal stent and method of assembly
US5609624A (en) 1993-10-08 1997-03-11 Impra, Inc. Reinforced vascular graft and method of making same
US5628786A (en) 1995-05-12 1997-05-13 Impra, Inc. Radially expandable vascular graft with resistance to longitudinal compression and method of making same
US5628782A (en) 1992-12-11 1997-05-13 W. L. Gore & Associates, Inc. Method of making a prosthetic vascular graft
US5628788A (en) 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
US5645559A (en) 1992-05-08 1997-07-08 Schneider (Usa) Inc Multiple layer stent
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5747128A (en) * 1996-01-29 1998-05-05 W. L. Gore & Associates, Inc. Radially supported polytetrafluoroethylene vascular graft
US5749880A (en) * 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5788626A (en) 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US5843166A (en) 1997-01-17 1998-12-01 Meadox Medicals, Inc. Composite graft-stent having pockets for accomodating movement
US6436135B1 (en) * 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62281953A (en) * 1986-05-28 1987-12-07 旭光学工業株式会社 Bone filler and its production
DE3879613T2 (en) * 1987-10-19 1993-10-07 Gore & Ass Quick reset PTFE and process for its manufacture.

Patent Citations (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953566A (en) 1970-05-21 1976-04-27 W. L. Gore & Associates, Inc. Process for producing porous products
US6436135B1 (en) * 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft
US4850999A (en) 1980-05-24 1989-07-25 Institute Fur Textil-Und Faserforschung Of Stuttgart Flexible hollow organ
US4954126B1 (en) 1982-04-30 1996-05-28 Ams Med Invent S A Prosthesis comprising an expansible or contractile tubular body
US4655771A (en) 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4954126A (en) 1982-04-30 1990-09-04 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4482516A (en) 1982-09-10 1984-11-13 W. L. Gore & Associates, Inc. Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure
WO1987004935A1 (en) 1986-02-24 1987-08-27 Fischell Robert An intravascular stent and percutaneous insertion system
US5061275A (en) 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5308664A (en) * 1987-10-19 1994-05-03 W. L. Gore & Associates, Inc. Rapidly recoverable PTFE and process therefore
DE3918736A1 (en) 1989-06-08 1990-12-13 Christian Dr Vallbracht PTFE coating for metal mesh prosthesis used in artery expansion - internal and external coatings are applied to mesh and prevent thrombosis and further arterial restriction
US5147385A (en) 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5234456A (en) 1990-02-08 1993-08-10 Pfizer Hospital Products Group, Inc. Hydrophilic stent
US5378239A (en) 1990-04-12 1995-01-03 Schneider (Usa) Inc. Radially expandable fixation member constructed of recovery metal
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5221261A (en) 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
US5123917A (en) 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5282824A (en) 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5112900A (en) 1990-11-28 1992-05-12 Tactyl Technologies, Inc. Elastomeric triblock copolymer compositions and articles made therewith
US5443909A (en) * 1991-12-06 1995-08-22 Kanzaki Paper Manufacturing Co., Ltd. Microcapsule containing ultraviolet absorber
EP0551179A1 (en) 1992-01-08 1993-07-14 Expandable Grafts Partnership Method and apparatus for bilateral intra-aortic bypass
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5645559A (en) 1992-05-08 1997-07-08 Schneider (Usa) Inc Multiple layer stent
US5269755A (en) * 1992-09-11 1993-12-14 Sherwood Medical Company Catheter with outer membrane medicament delivery system
US5466252A (en) * 1992-10-02 1995-11-14 W. L. Gore & Associates, Inc. Implantable lead
US5628782A (en) 1992-12-11 1997-05-13 W. L. Gore & Associates, Inc. Method of making a prosthetic vascular graft
EP0621015A1 (en) 1993-04-23 1994-10-26 Schneider (Europe) Ag Stent with a covering layer of elastic material and methods for applying the layer on the stent
WO1995005132A1 (en) 1993-08-18 1995-02-23 W.L. Gore & Associates, Inc. An intraluminal stent graft
WO1995005131A1 (en) 1993-08-18 1995-02-23 W.L. Gore & Associates, Inc. A tubular intraluminal graft
WO1995005555A1 (en) 1993-08-18 1995-02-23 W. L. Gore & Associates, Inc. A thin-wall polytetrafluoroethylene tube
US5993489A (en) 1993-08-18 1999-11-30 W. L. Gore & Associates, Inc. Tubular intraluminal graft and stent combination
US5718973A (en) 1993-08-18 1998-02-17 W. L. Gore & Associates, Inc. Tubular intraluminal graft
US5700285A (en) * 1993-08-18 1997-12-23 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5609624A (en) 1993-10-08 1997-03-11 Impra, Inc. Reinforced vascular graft and method of making same
WO1996000103A1 (en) 1994-06-27 1996-01-04 Endomed, Inc. Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith
US5607468A (en) 1994-11-04 1997-03-04 Aeroquip Corporation Method of manufacturing an intraluminal stenting graft
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5749880A (en) * 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
WO1996028115A1 (en) 1995-03-10 1996-09-19 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5628786A (en) 1995-05-12 1997-05-13 Impra, Inc. Radially expandable vascular graft with resistance to longitudinal compression and method of making same
WO1996040001A1 (en) 1995-06-07 1996-12-19 Baxter International Inc. Externally supported tape reinforced vascular graft
WO1997007751A1 (en) 1995-08-24 1997-03-06 Impra, Inc. Covered endoluminal stent and method of assembly
US5628788A (en) 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
US5788626A (en) 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US6165211A (en) * 1995-11-21 2000-12-26 Schneider (Usa) Inc. Expandable stent-graft covered with expanded polytetrafluoroethylene
US5747128A (en) * 1996-01-29 1998-05-05 W. L. Gore & Associates, Inc. Radially supported polytetrafluoroethylene vascular graft
US5607478A (en) 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US5843166A (en) 1997-01-17 1998-12-01 Meadox Medicals, Inc. Composite graft-stent having pockets for accomodating movement

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8303643B2 (en) 2001-06-27 2012-11-06 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US20090292352A1 (en) * 2002-06-27 2009-11-26 Boston Scientific Scimed, Inc. Methods of making medical devices
US20050216043A1 (en) * 2004-03-26 2005-09-29 Blatter Duane D Stented end graft vessel device for anastomosis and related methods for percutaneous placement
US20100023110A1 (en) * 2005-10-13 2010-01-28 Cook Incorporated Endoluminal Prosthesis
US20070088425A1 (en) * 2005-10-13 2007-04-19 Cook Incorporated Endoluminal prosthesis
US8043363B2 (en) 2005-10-13 2011-10-25 Cook Medical Technologies Llc Endoluminal prosthesis
US7670369B2 (en) * 2005-10-13 2010-03-02 Cook Incorporated Endoluminal prosthesis
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US20070178129A1 (en) * 2006-02-01 2007-08-02 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
US8057534B2 (en) 2006-09-15 2011-11-15 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US20080071353A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Endoprosthesis containing magnetic induction particles
US8128689B2 (en) 2006-09-15 2012-03-06 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis with biostable inorganic layers
US20080071348A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Medical Devices
US8052744B2 (en) 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20080071351A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Endoprosthesis with adjustable surface features
US7955382B2 (en) * 2006-09-15 2011-06-07 Boston Scientific Scimed, Inc. Endoprosthesis with adjustable surface features
US20080071358A1 (en) * 2006-09-18 2008-03-20 Boston Scientific Scimed, Inc. Endoprostheses
US20080097577A1 (en) * 2006-10-20 2008-04-24 Boston Scientific Scimed, Inc. Medical device hydrogen surface treatment by electrochemical reduction
US8715339B2 (en) 2006-12-28 2014-05-06 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8080055B2 (en) 2006-12-28 2011-12-20 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US11547548B2 (en) 2007-09-13 2023-01-10 W. L. Gore & Associates, Inc. Stented vascular graft
US20090076587A1 (en) * 2007-09-13 2009-03-19 Cully Edward H Stented Vascular Graft
US10080643B2 (en) 2007-09-13 2018-09-25 W. L. Gore Associates, Inc. Stented vascular graft
US9295542B2 (en) 2007-09-13 2016-03-29 W. L. Gore & Associates, Inc. Stented vascular graft
US9107744B2 (en) 2007-09-13 2015-08-18 W. L. Gore & Associates, Inc. Stented vascular graft
US8906081B2 (en) 2007-09-13 2014-12-09 W. L. Gore & Associates, Inc. Stented vascular graft
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US20090306765A1 (en) * 2008-06-10 2009-12-10 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
US20110118826A1 (en) * 2008-07-30 2011-05-19 Boston Scientific Scimed. Inc. Bioerodible Endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US20110160839A1 (en) * 2009-12-29 2011-06-30 Boston Scientific Scimed, Inc. Endoprosthesis
US20110190870A1 (en) * 2009-12-30 2011-08-04 Boston Scientific Scimed, Inc. Covered Stent for Vascular Closure
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses

Also Published As

Publication number Publication date
JP4087853B2 (en) 2008-05-21
ATE552800T1 (en) 2012-04-15
AU714991B2 (en) 2000-01-13
AU7187796A (en) 1997-05-29
JP2001231867A (en) 2001-08-28
JP2005111289A (en) 2005-04-28
ATE288715T1 (en) 2005-02-15
DE69634325T2 (en) 2005-06-30
US5788626A (en) 1998-08-04
MX9605796A (en) 1997-10-31
EP0775472A3 (en) 2000-04-12
JPH09173467A (en) 1997-07-08
CA2190717A1 (en) 1997-05-22
CA2190717C (en) 2002-09-10
EP0775472A2 (en) 1997-05-28
EP1530956A1 (en) 2005-05-18
JP3414956B2 (en) 2003-06-09
DE69634325D1 (en) 2005-03-17
EP0775472B1 (en) 2005-02-09
EP1530956B1 (en) 2012-04-11
US6165211A (en) 2000-12-26
US6524334B1 (en) 2003-02-25

Similar Documents

Publication Publication Date Title
USRE40122E1 (en) Expandable stent-graft covered with expanded polytetrafluoroethylene
US6336937B1 (en) Multi-stage expandable stent-graft
US6402779B1 (en) Balloon-assisted intraluminal stent graft
US5755774A (en) Bistable luminal graft endoprosthesis
JP3660355B2 (en) Intraluminal stent graft
EP1207815B1 (en) Tubular stent-graft composite device and method of manufacture
US5993489A (en) Tubular intraluminal graft and stent combination
AU712190B2 (en) Stented, radially expandable, tubular PTFE grafts
US6929709B2 (en) Helically formed stent/graft assembly
US20040220659A1 (en) Stent covering formed of porous polytetraflouroethylene
JP2002509456A (en) Coated stent
JP2004515275A (en) Composite tubular prosthesis
EP1767169B1 (en) Tubular stent-graft composite device and method of manufacture
MXPA96005796A (en) Expandable stent graft covered with polytetrafluoroethylene expand

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA

Free format text: MERGER;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:018454/0834

Effective date: 20050101

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCHNEIDER (USA) INC.;REEL/FRAME:018454/0858

Effective date: 19990427

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018454/0866

Effective date: 20050101

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: ACACIA RESEARCH GROUP LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:029940/0514

Effective date: 20121220

AS Assignment

Owner name: LIFEPORT SCIENCES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030003/0055

Effective date: 20121227

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: STARBOARD VALUE INTERMEDIATE FUND LP, AS COLLATERAL AGENT, NEW YORK

Free format text: PATENT SECURITY AGREEMENT;ASSIGNORS:ACACIA RESEARCH GROUP LLC;AMERICAN VEHICULAR SCIENCES LLC;BONUTTI SKELETAL INNOVATIONS LLC;AND OTHERS;REEL/FRAME:052853/0153

Effective date: 20200604

AS Assignment

Owner name: TELECONFERENCE SYSTEMS LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: PARTHENON UNIFIED MEMORY ARCHITECTURE LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: BONUTTI SKELETAL INNOVATIONS LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: R2 SOLUTIONS LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: SAINT LAWRENCE COMMUNICATIONS LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: NEXUS DISPLAY TECHNOLOGIES LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: AMERICAN VEHICULAR SCIENCES LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: MONARCH NETWORKING SOLUTIONS LLC, CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: LIMESTONE MEMORY SYSTEMS LLC, CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: LIFEPORT SCIENCES LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: CELLULAR COMMUNICATIONS EQUIPMENT LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: INNOVATIVE DISPLAY TECHNOLOGIES LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: SUPER INTERCONNECT TECHNOLOGIES LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: MOBILE ENHANCEMENT SOLUTIONS LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: UNIFICATION TECHNOLOGIES LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: ACACIA RESEARCH GROUP LLC, NEW YORK

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

Owner name: STINGRAY IP SOLUTIONS LLC, TEXAS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:STARBOARD VALUE INTERMEDIATE FUND LP;REEL/FRAME:053654/0254

Effective date: 20200630

AS Assignment

Owner name: STARBOARD VALUE INTERMEDIATE FUND LP, AS COLLATERAL AGENT, NEW YORK

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 052853 FRAME: 0153. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:LIFEPORT SCIENCES LLC;REEL/FRAME:056611/0120

Effective date: 20200604